[
  {
    "id": "0",
    "task": "multisubimageVQA",
    "model": "healthgpt",
    "question": "How do the coronary angiograms in Fig-1, Fig-3, and Fig-4 demonstrate the progression and treatment of coronary artery disease, particularly focusing on the occlusions and stenotic lesions?",
    "reference_answer": "The coronary angiograms in Fig-1, Fig-3, and Fig-4 illustrate the progression and treatment of coronary artery disease through detailed visualizations of occlusions and stenotic lesions. Fig-1 shows a total occlusion in the proximal left anterior descending artery, which was immediately treated with a drug-eluting stent upon hospitalization. Fig-3 highlights diffuse stenosis in the right coronary artery, successfully managed with drug-eluting stents on the following day. Fig-4 displays multiple stenotic lesions in the proximal and middle segments of the left circumflex artery, treated with drug-eluting stents on day 7 of hospitalization. These images collectively demonstrate the stepwise approach to treating significant coronary artery blockages, ensuring improved blood flow and reduced risk of myocardial ischemia.",
    "prediction": "The coronary angiograms in Fig-1, Fig-3, and Fig-4 provide a comprehensive view of the progression and treatment of coronary artery disease (CAD). In Fig-1, we observe significant stenotic lesions in the left anterior descending (LAD) artery and the left circumflex (LCX) artery. These stenoses are marked by arrows, indicating areas where the arterial lumen is narrowed, which can impede blood flow and increase the risk of myocardial infarction. Fig-3 shows a follow-up angiogram where the stenotic lesions in the LAD and LCX arteries have been treated, likely through percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG). The absence of significant stenosis in this image suggests successful revascularization, improving blood flow and reducing the risk of adverse cardiac events. In Fig-4, the angiogram of the right coronary artery (RCA) reveals an occlusion, marked by an arrow. This occlusion indicates a complete blockage in the RCA, which can lead to severe ischemia in the areas supplied by this artery. The presence of this occlusion highlights the need for further intervention to restore adequate blood flow and prevent potential complications such as myocardial infarction or heart failure. Overall, these images illustrate the dynamic nature of CAD and the importance of timely and effective treatment to manage and mitigate the risks associated with coronary artery blockages.",
    "metrics": {
      "bleu1": 0.31390134529147984,
      "bleu2": 0.23179918228015564,
      "bleu3": 0.16654376388069642,
      "bleu4": 0.12327890911302479,
      "rouge-1": 0.3861386092187041,
      "rouge-2": 0.2184300295705251,
      "rouge-l": 0.3564356389216744,
      "em": 0,
      "f1": 0.36893203883495146,
      "precision": 0.2923076923076923,
      "recall": 0.5,
      "bertscore_p": 0.669428825378418,
      "bertscore_r": 0.7170557975769043,
      "bertscore_f1": 0.6924242973327637,
      "bertsim": 0.8264192342758179,
      "cider": 4.768945277834998e-62
    }
  },
  {
    "id": "1",
    "task": "multisubimageVQA",
    "model": "healthgpt",
    "question": "How do the histological changes observed in Fig-4 and Fig-7 reflect the effectiveness of Zaltoprofen, Zileuton, and their combination in mitigating MNU-induced damage in mammary gland tissue?",
    "reference_answer": "In Fig-4, the MNU-treated group shows excessive formation of abscesses (AB) and lobules, indicative of significant inflammation and cellular proliferation. However, treatment with Zaltoprofen, Zileuton, or their combination effectively reduces these abnormalities, suggesting a protective effect against MNU-induced damage. In Fig-7, the H&E staining shows that the treatments maintain the presence of normal cellular structures such as ducts, adipocytes, lymphocytes, and various epithelial cells, indicating that the treatments preserve the overall cellular architecture and morphology. This suggests that the combination therapy has a more profound protective effect compared to monotherapy.",
    "prediction": "The histological changes observed in Fig-4 and Fig-7 provide significant insights into the effectiveness of Zaltoprofen, Zileuton, and their combination in mitigating MNU-induced damage in mammary gland tissue. In Fig-4, the MNU-treated group shows severe histological alterations, including disrupted glandular architecture, increased fibrosis, and inflammatory cell infiltration, indicating substantial tissue damage. In contrast, the groups treated with Zaltoprofen, Zileuton, and their combination exhibit varying degrees of histological improvement. The Zaltoprofen-treated group shows reduced fibrosis and better-preserved glandular structures compared to the MNU-treated group. Similarly, the Zileuton-treated group demonstrates decreased inflammatory cell infiltration and improved tissue architecture. The combination treatment group shows the most significant histological improvement, with minimal fibrosis, well-preserved glandular structures, and reduced inflammatory cell presence. These observations suggest that both Zaltoprofen and Zileuton are effective in mitigating MNU-induced damage, with the combination treatment providing the most substantial protective effect. This indicates a potential synergistic action of the two drugs in preserving mammary gland tissue integrity and reducing pathological changes induced by MNU.",
    "metrics": {
      "bleu1": 0.27325581395348836,
      "bleu2": 0.15482185970183304,
      "bleu3": 0.09457774672054908,
      "bleu4": 0.0622515772788632,
      "rouge-1": 0.34939758552474964,
      "rouge-2": 0.1130434736011344,
      "rouge-l": 0.3132530072114966,
      "em": 0,
      "f1": 0.30769230769230765,
      "precision": 0.25742574257425743,
      "recall": 0.38235294117647056,
      "bertscore_p": 0.6158690452575684,
      "bertscore_r": 0.6579905152320862,
      "bertscore_f1": 0.636233389377594,
      "bertsim": 0.7420762777328491,
      "cider": 7.111883874951383e-34
    }
  },
  {
    "id": "2",
    "task": "multisubimageVQA",
    "model": "healthgpt",
    "question": "How do the morphological changes in pMACs differ among the three treatments shown in Fig-1, Fig-2, and Fig-3?",
    "reference_answer": "The morphological changes in pMACs differ significantly among the three treatments:\n  - In Fig-1 (DMEM/F12-treated pMACs), the cells maintain normal morphology with a regular round shape, abundant clear cytoplasm, and ample intercellular spaces, indicating no signs of activation.\n  - In Fig-2 (TCM-treated pMACs), the cells show moderate activation with a polyhedral shape, large pseudopodia, abundant granules in the cytoplasm, and narrow intercellular spaces, indicating an active immune response.\n  - In Fig-3 (LPS-treated pMACs), the cells exhibit excessive activation with irregular shapes, doublet or multiple configurations, cell membrane blebbing, cell body atrophy, and nuclear condensation or fragmentation, indicating advanced stages of cell death.",
    "prediction": "The morphological changes in pMACs differ significantly among the three treatments. In Fig-1 (DMEM+F12), the pMACs exhibit a rounded morphology, which is typical for cells in a standard culture medium. In Fig-2 (TCM), the pMACs show a more elongated and spindle-shaped morphology, indicating a response to the TCM treatment. This change suggests that TCM influences the cytoskeletal organization and cell shape. In Fig-3 (0.5 μg/mL LPS), the pMACs display an even more pronounced elongated and spindle-shaped morphology compared to the TCM treatment. This indicates that LPS at this concentration further enhances the morphological changes induced by TCM, possibly due to an inflammatory response or other signaling pathways activated by LPS. These observations highlight the differential impact of each treatment on pMAC morphology, with LPS causing the most significant changes.",
    "metrics": {
      "bleu1": 0.291970802919708,
      "bleu2": 0.16050585556105426,
      "bleu3": 0.1151452410918375,
      "bleu4": 0.0945002169394889,
      "rouge-1": 0.32258064022143607,
      "rouge-2": 0.1148325309814338,
      "rouge-l": 0.3096774144149844,
      "em": 0,
      "f1": 0.30379746835443033,
      "precision": 0.2727272727272727,
      "recall": 0.34285714285714286,
      "bertscore_p": 0.6358222961425781,
      "bertscore_r": 0.6529680490493774,
      "bertscore_f1": 0.6442811489105225,
      "bertsim": 0.8206248879432678,
      "cider": 3.033792486073888e-05
    }
  },
  {
    "id": "3",
    "task": "multisubimageVQA",
    "model": "healthgpt",
    "question": "What specific brain regions and their corresponding MNI coordinates are highlighted in the sagittal MRI views (Fig-1, Fig-2, Fig-3) to show significant negative correlations between gray-matter volume and TAS-20 total or DIF scores?",
    "reference_answer": "The sagittal MRI views (Fig-1, Fig-2, Fig-3) highlight specific brain regions with significant negative correlations between gray-matter volume and TAS-20 total or DIF scores. These regions include the anterior cingulate cortex (ACC) and the left inferior frontal gyrus, with MNI coordinates indicating the precise locations of these clusters. The statistical significance is set at p < 0.005, and the cluster sizes exceed 100 mm³, providing evidence that reduced gray-matter volume in these areas is associated with increased alexithymia severity and difficulties in identifying emotions among ALS patients.",
    "prediction": "The sagittal MRI views (Fig-1, Fig-2, Fig-3) highlight significant negative correlations between gray-matter volume and TAS-20 total or DIF scores in the following brain regions and their corresponding MNI coordinates:\n\n1. Fig-1 (TAS-20 total score):\n   - Left superior temporal gyrus (MNI coordinates: -30, -20, -20)\n   - Right superior temporal gyrus (MNI coordinates: 30, -20, -20)\n\n2. Fig-2 (TAS-20 DIF score):\n   - Left superior temporal gyrus (MNI coordinates: -30, -20, -20)\n   - Right superior temporal gyrus (MNI coordinates: 30, -20, -20)\n\n3. Fig-3 (TAS-20 DIF score):\n   - Left superior temporal gyrus (MNI coordinates: -30, -20, -20)\n   - Right superior temporal gyrus (MNI coordinates: 30, -20, -20)\n\nThese findings suggest that lower gray-matter volume in the superior temporal gyrus regions is associated with higher TAS-20 total and DIF scores, indicating a potential relationship between these brain regions and alexithymia.",
    "metrics": {
      "bleu1": 0.31914893617021284,
      "bleu2": 0.2289794989562368,
      "bleu3": 0.18935799019454444,
      "bleu4": 0.1620037113383605,
      "rouge-1": 0.48120300254169257,
      "rouge-2": 0.2634730488938292,
      "rouge-l": 0.4511278145717678,
      "em": 0,
      "f1": 0.4545454545454545,
      "precision": 0.4838709677419355,
      "recall": 0.42857142857142855,
      "bertscore_p": 0.5056818723678589,
      "bertscore_r": 0.6354702711105347,
      "bertscore_f1": 0.5631953477859497,
      "bertsim": 0.756488025188446,
      "cider": 9.291353051275533e-16
    }
  },
  {
    "id": "4",
    "task": "multisubimageVQA",
    "model": "healthgpt",
    "question": "How do the axial and sagittal views (Fig-1 and Fig-3) assist in verifying the precise alignment of the target volume and critical structures during HyperArc VMAT SRT treatment?",
    "reference_answer": "The axial view (Fig-1) shows a distinct red region representing the target volume near the spinal column, with various colored contours indicating different radiation dose levels. This visualization ensures precise targeting and dose distribution. The sagittal view (Fig-3) provides a comprehensive overview of key anatomical structures such as the skull, brainstem, and cervical vertebrae, along with contours delineating target volumes and organs at risk. Together, these views confirm the accurate alignment of the target volume and critical structures, ensuring safe and effective radiation delivery.",
    "prediction": "The axial and sagittal views (Fig-1 and Fig-3) are crucial for verifying the precise alignment of the target volume and critical structures during HyperArc VMAT SRT treatment. The axial view (Fig-1) provides a cross-sectional perspective, allowing for the assessment of the target volume's position relative to the spinal cord and other critical structures in the transverse plane. The sagittal view (Fig-3) offers a longitudinal perspective, enabling the evaluation of the target volume's alignment along the length of the spine. By comparing these views, clinicians can ensure that the target volume is accurately positioned and that critical structures are adequately spared, thereby optimizing the treatment plan and minimizing the risk of complications.",
    "metrics": {
      "bleu1": 0.3565217391304348,
      "bleu2": 0.23057650032452773,
      "bleu3": 0.17297424461293973,
      "bleu4": 0.13410843249413712,
      "rouge-1": 0.3181818131864096,
      "rouge-2": 0.1555555506055557,
      "rouge-l": 0.30303029803489445,
      "em": 0,
      "f1": 0.30075187969924816,
      "precision": 0.2898550724637681,
      "recall": 0.3125,
      "bertscore_p": 0.6664254665374756,
      "bertscore_r": 0.6693292856216431,
      "bertscore_f1": 0.6678742170333862,
      "bertsim": 0.6741970777511597,
      "cider": 6.441636059841051e-05
    }
  },
  {
    "id": "5",
    "task": "multisubimageVQA",
    "model": "healthgpt",
    "question": "How do the histological features of cholesteatoma (Fig-1) differ from those of normal external ear skin (Fig-2)?",
    "reference_answer": "The histological features of cholesteatoma (Fig-1) include a hyperproliferative stratified squamous epithelium (matrix), an inflammatory cell-rich perimatrix, and a cystic layer composed of desquamated, anucleate keratin mass. In contrast, normal external ear skin (Fig-2) shows an intact epithelium and subepithelial connective tissue with hair follicles, indicating a healthy structure without any signs of inflammation or abnormal cell proliferation.",
    "prediction": "The histological features of cholesteatoma (Fig-1) differ significantly from those of normal external ear skin (Fig-2) in several ways. In Fig-1, the cholesteatoma is characterized by the presence of keratinizing squamous epithelium, as indicated by the yellow arrow. This type of epithelium is not typically found in normal external ear skin. Additionally, Fig-1 shows a dense infiltration of inflammatory cells, marked by the blue arrow, which is indicative of an active inflammatory process. In contrast, Fig-2, which represents normal external ear skin, does not exhibit keratinizing squamous epithelium or significant inflammatory cell infiltration. The normal external ear skin is composed of stratified squamous epithelium without keratinization and lacks the dense inflammatory cell presence seen in cholesteatoma. These differences highlight the pathological changes associated with cholesteatoma, including epithelial keratinization and inflammation, which are absent in normal external ear skin.",
    "metrics": {
      "bleu1": 0.2206896551724138,
      "bleu2": 0.1464784581340137,
      "bleu3": 0.1105311437140806,
      "bleu4": 0.08303934462154738,
      "rouge-1": 0.39393938919765836,
      "rouge-2": 0.14772726834775324,
      "rouge-l": 0.3636363588946281,
      "em": 0,
      "f1": 0.3851851851851852,
      "precision": 0.30952380952380953,
      "recall": 0.5098039215686274,
      "bertscore_p": 0.6002704501152039,
      "bertscore_r": 0.6412975788116455,
      "bertscore_f1": 0.6201061010360718,
      "bertsim": 0.8818742632865906,
      "cider": 2.8174400139028183e-39
    }
  },
  {
    "id": "6",
    "task": "multisubimageVQA",
    "model": "healthgpt",
    "question": "How do the MRI sections (Fig-1, Fig-3, and Fig-4) contribute to understanding the specific brain regions affected and the corresponding cognitive and behavioral impairments in a patient with frontotemporal dementia (FTD)?",
    "reference_answer": "The MRI sections provide critical insights into the brain regions affected in FTD. Fig-1 shows overall cortical atrophy with volumetric reduction and widened sulci, indicative of widespread neurodegeneration. Fig-3 highlights the anterior coronal section, revealing atrophy in the superior, middle, and inferior frontal gyri, correlating with impairments in operative memory, learning, and consolidation, as well as aberrant motor behavior and aggression. Fig-4 illustrates the middle sagittal section, showing atrophy in the marginal callosum fissure, subparietal sulci, and frontal regions, leading to dysexecutive syndrome and impaired decision-making abilities. Together, these sections provide a comprehensive view of the specific brain regions affected and their corresponding cognitive and behavioral deficits in FTD.",
    "prediction": "The MRI sections (Fig-1, Fig-3, and Fig-4) provide critical insights into the specific brain regions affected in a patient with frontotemporal dementia (FTD) and the corresponding cognitive and behavioral impairments. Fig-1, a T1-weighted MRI, shows significant atrophy in the frontal and anterior temporal lobes, which are crucial for executive functions, decision-making, and social behavior. This atrophy correlates with the patient's difficulties in these areas. Fig-3, a T2-weighted MRI, highlights increased signal intensity in the same regions, indicating gliosis or other pathological changes, further supporting the diagnosis of FTD. Fig-4, a FLAIR MRI, shows hyperintense signals in the frontal and anterior temporal lobes, suggesting the presence of edema or demyelination, which are common in neurodegenerative diseases like FTD. Together, these images provide a comprehensive view of the structural brain changes associated with FTD, helping to explain the patient's cognitive and behavioral symptoms.",
    "metrics": {
      "bleu1": 0.41496598639455784,
      "bleu2": 0.2718419621243814,
      "bleu3": 0.20127738941111034,
      "bleu4": 0.1502506112766316,
      "rouge-1": 0.3859649073191752,
      "rouge-2": 0.19130434288998122,
      "rouge-l": 0.3508771880209296,
      "em": 0,
      "f1": 0.3625730994152046,
      "precision": 0.3333333333333333,
      "recall": 0.3974358974358974,
      "bertscore_p": 0.6950892210006714,
      "bertscore_r": 0.7313920855522156,
      "bertscore_f1": 0.7127787470817566,
      "bertsim": 0.7509060502052307,
      "cider": 1.1143121872797232e-06
    }
  },
  {
    "id": "7",
    "task": "multisubimageVQA",
    "model": "healthgpt",
    "question": "What do the fluorescence microscopy images (Fig-3 and Fig-5) reveal about the presence or absence of COX-1 in platelets and leukocytes from control and COX-1 knockout mice?",
    "reference_answer": "The fluorescence microscopy images (Fig-3 and Fig-5) demonstrate the absence of COX-1 (magenta staining) in platelets from COX-1 knockout (KO) mice, as seen in both Fig-3 and Fig-5. In contrast, COX-1 is present in certain leukocytes, as evidenced by the magenta spots in Fig-5. This confirms the specific targeting of COX-1 in platelets while maintaining its expression in certain immune cells.",
    "prediction": "The fluorescence microscopy images (Fig-3 and Fig-5) reveal the presence or absence of COX-1 in platelets and leukocytes from control and COX-1 knockout mice. In Fig-3, platelets from control mice show green fluorescence, indicating the presence of COX-1, while platelets from COX-1 knockout mice do not show this fluorescence, confirming the absence of COX-1. Similarly, in Fig-5, leukocytes from control mice exhibit green fluorescence, indicating COX-1 presence, whereas leukocytes from COX-1 knockout mice lack this fluorescence, confirming the absence of COX-1. These observations suggest that COX-1 is present in both platelets and leukocytes of control mice but is absent in these cells of COX-1 knockout mice.",
    "metrics": {
      "bleu1": 0.32727272727272727,
      "bleu2": 0.24505110018405926,
      "bleu3": 0.19335005652989928,
      "bleu4": 0.15247013325643963,
      "rouge-1": 0.44444443945432105,
      "rouge-2": 0.2686567115292939,
      "rouge-l": 0.3999999950098766,
      "em": 0,
      "f1": 0.4130434782608695,
      "precision": 0.3877551020408163,
      "recall": 0.4418604651162791,
      "bertscore_p": 0.6177944540977478,
      "bertscore_r": 0.6634065508842468,
      "bertscore_f1": 0.6397886276245117,
      "bertsim": 0.8868796825408936,
      "cider": 1.0888369920687234e-12
    }
  },
  {
    "id": "8",
    "task": "multisubimageVQA",
    "model": "healthgpt",
    "question": "How do the selected sub-images (Fig-1, Fig-5, Fig-6) illustrate the differences in Akt phosphorylation between HNSCC tissues and normal tissues, and what does this indicate about Akt activity in tumor versus non-tumor regions?",
    "reference_answer": "The selected sub-images show distinct differences in Akt phosphorylation between HNSCC tissues and normal tissues. Fig-1 depicts more intense staining of pAkt S473 and pAkt T308 in HNSCC tissues compared to normal tissues, indicating elevated Akt activity in cancerous cells. Fig-5 highlights a significant increase in phosphorylation at Akt T308 compared to S473 in HNSCC patient samples, suggesting a preferential activation of the Akt signaling pathway at T308. Fig-6 demonstrates very weak or no phosphorylation of Akt at both T308 and S473 in the non-tumor part of HNSCC tissues, indicating minimal Akt activity in these regions. Collectively, these images illustrate the localized and enhanced Akt activity in tumor regions compared to non-tumor areas, which may be relevant for understanding tumor progression and potential therapeutic targets.",
    "prediction": "The selected sub-images (Fig-1, Fig-5, Fig-6) illustrate significant differences in Akt phosphorylation between HNSCC tissues and normal tissues. In HNSCC tissues, there is a marked increase in phosphorylated Akt (p-Akt) levels compared to normal tissues. This is evident from the intense staining in the tumor regions, indicating high Akt activity. In contrast, normal tissues show minimal p-Akt staining, suggesting low Akt activity. This differential staining highlights the role of Akt in tumor progression, as increased Akt phosphorylation is often associated with enhanced cell survival, proliferation, and resistance to apoptosis in cancer cells. Therefore, the images suggest that Akt is more active in tumor regions, contributing to the aggressive behavior of HNSCC.",
    "metrics": {
      "bleu1": 0.5047811530747727,
      "bleu2": 0.3120075506650852,
      "bleu3": 0.20273249735153615,
      "bleu4": 0.15124292781181656,
      "rouge-1": 0.45517240879334125,
      "rouge-2": 0.21100916932244773,
      "rouge-l": 0.39999999500023786,
      "em": 0,
      "f1": 0.44,
      "precision": 0.44594594594594594,
      "recall": 0.4342105263157895,
      "bertscore_p": 0.7376717329025269,
      "bertscore_r": 0.7085692286491394,
      "bertscore_f1": 0.722827672958374,
      "bertsim": 0.8961090445518494,
      "cider": 0.1483612887582922
    }
  },
  {
    "id": "9",
    "task": "multisubimageVQA",
    "model": "healthgpt",
    "question": "How does the presence or absence of LNG-IUD affect breast parenchymal enhancement (BPE) as seen in the selected sub-images (Fig-1, Fig-3, and Fig-4)?",
    "reference_answer": "The presence of an LNG-IUD is associated with higher levels of breast parenchymal enhancement (BPE) as seen in the selected sub-images. Fig-1 shows a woman with an LNG-IUD in place for three years, with BPE categorized as MR-ACR 3. Fig-3 depicts a woman without an LNG-IUD, with BPE categorized as MR-ACR 2. Fig-4 illustrates a woman who recently had an LNG-IUD inserted, with BPE categorized as MR-ACR 4. These findings indicate that LNG-IUD use can lead to increased BPE, with more pronounced enhancement seen shortly after insertion compared to longer-term use.",
    "prediction": "The selected sub-images (Fig-1, Fig-3, and Fig-4) provide a comparative analysis of breast parenchymal enhancement (BPE) with and without the presence of a levonorgestrel-releasing intrauterine device (LNG-IUD). In Fig-1 (A.1), the BPE is observed in the absence of an LNG-IUD, showing a baseline level of enhancement. In contrast, Fig-3 (B.1) and Fig-4 (B.2) depict BPE in the presence of an LNG-IUD. The images suggest that the presence of an LNG-IUD does not significantly alter the BPE, as the enhancement patterns remain consistent with those observed without the device. This indicates that the LNG-IUD does not have a substantial impact on breast parenchymal enhancement, maintaining similar levels of enhancement regardless of its presence.",
    "metrics": {
      "bleu1": 0.3499999999999999,
      "bleu2": 0.20291986247835692,
      "bleu3": 0.1346754340062092,
      "bleu4": 0.09559492135182514,
      "rouge-1": 0.38759689424914373,
      "rouge-2": 0.1460674108067165,
      "rouge-l": 0.29457363843519024,
      "em": 0,
      "f1": 0.36363636363636365,
      "precision": 0.3380281690140845,
      "recall": 0.39344262295081966,
      "bertscore_p": 0.656864583492279,
      "bertscore_r": 0.6493754386901855,
      "bertscore_f1": 0.6530985236167908,
      "bertsim": 0.8719788193702698,
      "cider": 0.0026205584375494414
    }
  },
  {
    "id": "10",
    "task": "multisubimageVQA",
    "model": "healthgpt",
    "question": "How does the immunocolocalization analysis of Hyccin-LacZ activity with NeuN (Fig-1) and GFAP (Fig-3) differ, and what does this suggest about the cellular distribution of Hyccin-LacZ activity in the CNS?",
    "reference_answer": "The immunocolocalization analysis in Fig-1 shows that Hyccin-LacZ activity colocalizes with the neuronal marker NeuN, indicating its expression in neurons. In contrast, Fig-3 reveals that Hyccin-LacZ activity does not significantly colocalize with the astrocyte marker GFAP, suggesting a lack of interaction with astrocytes. This differential colocalization indicates that Hyccin-LacZ activity is primarily restricted to neuronal cells in the developing CNS, rather than extending to astrocytic populations.",
    "prediction": "The immunocolocalization analysis of Hyccin-LacZ activity with NeuN (Fig-1) and GFAP (Fig-3) shows distinct differences in cellular distribution. In Fig-1, Hyccin-LacZ activity colocalizes with NeuN, a neuronal marker, indicating that Hyccin-LacZ is expressed in neurons. This suggests that Hyccin-LacZ plays a role in neuronal cells within the CNS. In contrast, Fig-3 shows Hyccin-LacZ activity colocalizing with GFAP, an astrocytic marker, indicating that Hyccin-LacZ is also expressed in astrocytes. This dual localization suggests that Hyccin-LacZ has a broader role in the CNS, affecting both neuronal and glial cells. The presence of Hyccin-LacZ in both cell types could imply its involvement in various CNS functions, including neuronal signaling and glial support.",
    "metrics": {
      "bleu1": 0.3826086956521739,
      "bleu2": 0.2525234958217334,
      "bleu3": 0.158079077954596,
      "bleu4": 0.09164500279902352,
      "rouge-1": 0.46017698623854647,
      "rouge-2": 0.1548387049323623,
      "rouge-l": 0.4424778711942987,
      "em": 0,
      "f1": 0.45217391304347826,
      "precision": 0.3939393939393939,
      "recall": 0.5306122448979592,
      "bertscore_p": 0.7063743472099304,
      "bertscore_r": 0.7287399768829346,
      "bertscore_f1": 0.7173828482627869,
      "bertsim": 0.9204916954040527,
      "cider": 1.1802269153509178e-11
    }
  },
  {
    "id": "11",
    "task": "multisubimageVQA",
    "model": "healthgpt",
    "question": "How does the immunostaining pattern of Bit1 differ between the adenocarcinoma (Fig-6) and large cell carcinoma (Fig-8) sub-images, and what might these differences imply about Bit1 expression and tumor aggressiveness?",
    "reference_answer": "In the adenocarcinoma (Fig-6), the Bit1 staining is heterogeneous, indicating variable expression levels of the Bit1 protein within the tumor cells. This suggests that Bit1 expression may vary across different regions of the adenocarcinoma, potentially correlating with specific pathological features or tumor aggressiveness. In contrast, the large cell carcinoma (Fig-8) exhibits significant cellular atypia, pleomorphism, and active proliferation, indicative of aggressive tumor behavior. The lack of strong Bit1 staining in these areas implies a lower expression of Bit1, which may contribute to the enhanced aggressiveness and resistance to anoikis in large cell carcinomas.",
    "prediction": "The immunostaining pattern of Bit1 in the adenocarcinoma sub-image (Fig-6) shows a more uniform and intense staining compared to the large cell carcinoma sub-image (Fig-8), where the staining appears more heterogeneous and less intense. These differences suggest that Bit1 expression is higher and more consistent in adenocarcinoma compared to large cell carcinoma. This could imply that Bit1 plays a more significant role in the pathogenesis or progression of adenocarcinoma, potentially contributing to its biological behavior and aggressiveness.",
    "metrics": {
      "bleu1": 0.40428015816072627,
      "bleu2": 0.22283043194830207,
      "bleu3": 0.12721615692783295,
      "bleu4": 0.0681886556326724,
      "rouge-1": 0.3999999950850662,
      "rouge-2": 0.11392404569780505,
      "rouge-l": 0.34782608204158794,
      "em": 0,
      "f1": 0.3728813559322034,
      "precision": 0.4230769230769231,
      "recall": 0.3333333333333333,
      "bertscore_p": 0.7056034207344055,
      "bertscore_r": 0.6806011199951172,
      "bertscore_f1": 0.6928768157958984,
      "bertsim": 0.8826959729194641,
      "cider": 0.042391552531523324
    }
  },
  {
    "id": "12",
    "task": "multisubimageVQA",
    "model": "healthgpt",
    "question": "How do the photomicrographs and quantitative analysis of TUNEL-positive cells in the selected sub-images (Fig-2, Fig-3, and Fig-4) demonstrate the effects of AGP supplementation on apoptosis in myocardial tissue?",
    "reference_answer": "The photomicrographs in Fig-2 and Fig-3 show a marked reduction in the number of apoptotic cells, identified by darkly stained nuclei with fragmented appearances, in the AGP-treated group compared to the control group. This is particularly evident in the border zone (BZ), where cellular integrity appears more preserved. Fig-4 provides quantitative support, showing significantly lower ratios of TUNEL-positive cells to total cells in the AGP-treated group, with a statistically significant difference (*P < 0.05) compared to the control group. These findings collectively suggest that AGP supplementation has a protective effect against apoptosis in myocardial tissue.",
    "prediction": "The photomicrographs in Fig-2, Fig-3, and Fig-4, along with the quantitative analysis in Fig-3B, provide a comprehensive view of the effects of AGP supplementation on apoptosis in myocardial tissue. In Fig-2, the TUNEL-positive cells, indicated by black arrows, are significantly reduced in the AGP-supplemented group compared to the control group, suggesting a protective effect of AGP against apoptosis. This observation is quantitatively supported by Fig-3B, where the bar graph shows a marked decrease in the percentage of TUNEL-positive cells in the AGP group compared to the control group, with statistical significance (p < 0.05). Similarly, Fig-4 shows a reduction in TUNEL-positive cells in the AGP-supplemented group, further corroborating the protective role of AGP. These findings collectively indicate that AGP supplementation effectively reduces apoptosis in myocardial tissue, as evidenced by both qualitative and quantitative analyses.",
    "metrics": {
      "bleu1": 0.45,
      "bleu2": 0.3317709186261556,
      "bleu3": 0.2336894872156504,
      "bleu4": 0.15375776322306883,
      "rouge-1": 0.5064935015069996,
      "rouge-2": 0.24630541382125273,
      "rouge-l": 0.46753246254596054,
      "em": 0,
      "f1": 0.4774193548387097,
      "precision": 0.45121951219512196,
      "recall": 0.5068493150684932,
      "bertscore_p": 0.7152724862098694,
      "bertscore_r": 0.7518571615219116,
      "bertscore_f1": 0.733108639717102,
      "bertsim": 0.89051353931427,
      "cider": 9.55017213201478e-10
    }
  },
  {
    "id": "13",
    "task": "multisubimageVQA",
    "model": "healthgpt",
    "question": "What joint manifestations are observed in the patient and her father as depicted in Fig-1 and Fig-5, and how do these findings reflect the hereditary aspect of Blau syndrome?",
    "reference_answer": "Fig-1 shows the patient with fixed flexion deformities at the proximal interphalangeal joints of the fourth and fifth fingers of both hands, characterized by abnormal curvature and immobility. Fig-5 depicts the father with residual deformities at the proximal interphalangeal joints of both hands and feet, marked by joint swelling, misalignment, and possible joint space narrowing or erosions. These findings reflect the hereditary aspect of Blau syndrome, as similar joint manifestations are present in both the patient and her father, indicating a familial pattern of inheritance.",
    "prediction": "In Fig-1, the patient exhibits synovitis in the metacarpophalangeal (MCP), proximal interphalangeal (PIP), and distal interphalangeal (DIP) joints of both hands, as well as in the metatarsophalangeal (MTP), proximal interphalangeal (PIP), and distal interphalangeal (DIP) joints of both feet. This widespread joint inflammation is characteristic of Blau syndrome. In Fig-5, the patient's father shows similar joint involvement, with synovitis in the MCP, PIP, and DIP joints of both hands and the MTP, PIP, and DIP joints of both feet. The presence of similar joint manifestations in both the patient and her father highlights the hereditary nature of Blau syndrome, suggesting a genetic predisposition to this inflammatory condition.",
    "metrics": {
      "bleu1": 0.43243243243243246,
      "bleu2": 0.28039985489311264,
      "bleu3": 0.19321597184297726,
      "bleu4": 0.13518198833235054,
      "rouge-1": 0.3965517191394174,
      "rouge-2": 0.20125785664491133,
      "rouge-l": 0.2931034432773485,
      "em": 0,
      "f1": 0.39655172413793105,
      "precision": 0.40350877192982454,
      "recall": 0.3898305084745763,
      "bertscore_p": 0.7061445713043213,
      "bertscore_r": 0.7083207368850708,
      "bertscore_f1": 0.7072309851646423,
      "bertsim": 0.7355514764785767,
      "cider": 0.002187890622411153
    }
  },
  {
    "id": "14",
    "task": "multisubimageVQA",
    "model": "healthgpt",
    "question": "How do the cell viability results (Fig-1) and the endocytosis of LP-A96 after dynasore removal (Fig-6) support the reversibility and specificity of dynasore's inhibitory effect?",
    "reference_answer": "Fig-1 shows that dynasore does not cause cell death, as there is no significant fluorescence from annexin V and propidium iodide staining. This indicates that dynasore specifically inhibits endocytosis without affecting cell viability. Fig-6 demonstrates that after removing dynasore and allowing cells to recover for 4 hours, LP-A96 is successfully internalized, as seen by the red fluorescence. This supports the conclusion that dynasore's inhibitory effect on endocytosis is reversible, confirming its specificity and utility in studying cellular uptake mechanisms.",
    "prediction": "The cell viability results (Fig-1) indicate that dynasore does not significantly affect cell viability, suggesting that its inhibitory effects are specific to endocytosis rather than general cytotoxicity. The endocytosis of LP-A96 after dynasore removal (Fig-6) demonstrates that the inhibition of endocytosis by dynasore is reversible, as the cells regain their ability to internalize LP-A96 once dynasore is removed. This supports the conclusion that dynasore specifically inhibits dynamin-mediated endocytosis without causing long-term damage to the cells.",
    "metrics": {
      "bleu1": 0.44490545585203356,
      "bleu2": 0.2851113048846028,
      "bleu3": 0.20021131900014164,
      "bleu4": 0.14966967232964323,
      "rouge-1": 0.42735042239462345,
      "rouge-2": 0.1756756706838935,
      "rouge-l": 0.3589743540185551,
      "em": 0,
      "f1": 0.40336134453781514,
      "precision": 0.4444444444444444,
      "recall": 0.36923076923076925,
      "bertscore_p": 0.7432804107666016,
      "bertscore_r": 0.7223051190376282,
      "bertscore_f1": 0.7326427102088928,
      "bertsim": 0.8747280240058899,
      "cider": 1.4461703013239275
    }
  },
  {
    "id": "15",
    "task": "multisubimageVQA",
    "model": "healthgpt",
    "question": "What morphological differences are evident in the outflow tract (OFT) and overall cardiac structure between the control and mutant embryos as shown in Fig-3 and Fig-6?",
    "reference_answer": "In Fig-3, the control OFT sections display normal endothelial cell (Pecam) and GFP expression patterns, indicating proper myocardial tissue localization and gene activity. In contrast, mutant OFT sections exhibit disruptions in the endothelial cell layer and altered GFP expression, suggesting impaired gene function and abnormal development. Fig-6 further illustrates these differences, showing a normal cardiac structure in the control sample with clear atria and ventricle boundaries. Mutant samples, however, present significant structural abnormalities, including double outlet right ventricle (DORV) and persistent truncus arteriosus (PTA), indicating disrupted OFT development due to gene deletions.",
    "prediction": "In the control embryos (Fig-3), the outflow tract (OFT) is well-defined and continuous, indicating normal cardiac development. In contrast, the mutant embryos (Fig-6) exhibit a discontinuous OFT, which is a significant morphological abnormality. Additionally, the overall cardiac structure in the mutant embryos appears less organized and more disordered compared to the control embryos. This suggests that the Pax3-Cre;Dullard flox/flox mutation leads to severe disruptions in cardiac development, particularly affecting the formation and continuity of the OFT.",
    "metrics": {
      "bleu1": 0.30702403240424325,
      "bleu2": 0.1870852438855321,
      "bleu3": 0.11369163715814427,
      "bleu4": 0.06287224742647297,
      "rouge-1": 0.28099173061402916,
      "rouge-2": 0.08917196958091635,
      "rouge-l": 0.24793387937435973,
      "em": 0,
      "f1": 0.26016260162601623,
      "precision": 0.2962962962962963,
      "recall": 0.2318840579710145,
      "bertscore_p": 0.6576010584831238,
      "bertscore_r": 0.6490821838378906,
      "bertscore_f1": 0.6533138155937195,
      "bertsim": 0.6570644378662109,
      "cider": 0.015340729115354324
    }
  },
  {
    "id": "16",
    "task": "multisubimageVQA",
    "model": "healthgpt",
    "question": "How do the selected sub-images (Fig-1, Fig-4, and Fig-5) illustrate the impact of purple rice bran extract and protocatechuic acid on cell proliferation and apoptosis in liver tissue?",
    "reference_answer": "The selected sub-images show that in the experimental animals treated with DEN + PCA, there is a significant increase in GST-P expression (intense red staining), elevated PCNA levels (increased brown staining), and enhanced apoptotic activity (darkly stained nuclei via TUNEL). These findings suggest that the treatment induces higher cell turnover and increased programmed cell death, indicating that PCA and PRBE may modulate cellular processes involved in liver health by reducing cell proliferation and inducing apoptosis.",
    "prediction": "The selected sub-images (Fig-1, Fig-4, and Fig-5) illustrate the impact of purple rice bran extract (PRBC) and protocatechuic acid (PCA) on cell proliferation and apoptosis in liver tissue through the use of specific staining techniques. In Fig-1, TUNEL staining is used to identify apoptotic cells, which are marked by black arrows. This staining highlights the presence of DNA fragmentation, a hallmark of apoptosis. In Fig-4 and Fig-5, PCNA staining is employed to detect proliferating cells, indicated by black arrows. PCNA is a marker for cell proliferation, and its presence suggests active cell division. By comparing these images, we can observe the effects of PRBC and PCA on both apoptosis and proliferation in liver tissue. For instance, an increase in TUNEL-positive cells would indicate higher rates of apoptosis, while an increase in PCNA-positive cells would suggest enhanced cell proliferation. These observations can help in understanding the therapeutic potential of PRBC and PCA in modulating liver cell dynamics.",
    "metrics": {
      "bleu1": 0.1890243902439024,
      "bleu2": 0.10216129170419422,
      "bleu3": 0.05050827976012652,
      "bleu4": 1.3012419051467073e-78,
      "rouge-1": 0.25157232225940435,
      "rouge-2": 0.06481481031035696,
      "rouge-l": 0.2264150895550019,
      "em": 0,
      "f1": 0.24691358024691362,
      "precision": 0.20202020202020202,
      "recall": 0.31746031746031744,
      "bertscore_p": 0.5655896067619324,
      "bertscore_r": 0.6202782392501831,
      "bertscore_f1": 0.5916728973388672,
      "bertsim": 0.6822115778923035,
      "cider": 1.1825643306319605e-40
    }
  },
  {
    "id": "17",
    "task": "multisubimageVQA",
    "model": "healthgpt",
    "question": "What specific brain regions exhibit decreased beta-band activity during sustained threat of unpredictable shock, as shown in the selected sub-images (Fig-3 and Fig-4)?",
    "reference_answer": "In both Fig-3 and Fig-4, the selected sub-images demonstrate decreased beta-band activity in the sensorimotor and right prefrontal cortex. These regions show significant reductions in mean beta power ratios (THREAT/SAFE, log10-transformed), indicating reduced neural engagement in these critical cognitive and motor control areas under conditions of unpredictability and potential harm. The color-coded brain maps and pial surface reconstructions overlay t-statistic maps, providing visual evidence of these changes.",
    "prediction": "The specific brain regions exhibiting decreased beta-band activity during sustained threat of unpredictable shock, as shown in the selected sub-images (Fig-3 and Fig-4), are primarily located in the prefrontal cortex and the anterior cingulate cortex.",
    "metrics": {
      "bleu1": 0.19444778199461146,
      "bleu2": 0.12297957541417023,
      "bleu3": 0.0702020857541249,
      "bleu4": 1.3153970599230278e-78,
      "rouge-1": 0.30952380500283455,
      "rouge-2": 0.12121211676767694,
      "rouge-l": 0.2619047573837869,
      "em": 0,
      "f1": 0.3058823529411765,
      "precision": 0.43333333333333335,
      "recall": 0.23636363636363636,
      "bertscore_p": 0.7583543658256531,
      "bertscore_r": 0.633662223815918,
      "bertscore_f1": 0.6904234886169434,
      "bertsim": 0.6715043783187866,
      "cider": 5.38538065675308e-07
    }
  },
  {
    "id": "18",
    "task": "multisubimageVQA",
    "model": "healthgpt",
    "question": "How does the combined analysis of the immunofluorescence images (Fig-1 and Fig-4) and the Western blot (Fig-3) contribute to understanding the expression and localization of PHB1 in the vascular system?",
    "reference_answer": "The combined analysis of the selected sub-images provides a comprehensive view of PHB1 expression and localization in the vascular system. Fig-1 shows PHB1 expression in both SMCs and ECs within mouse aortic sections, indicating its broad distribution in vascular tissues. Fig-4 reveals that PHB1 localizes primarily to mitochondria within ECs, suggesting its involvement in mitochondrial functions such as energy production and apoptosis regulation. Fig-3 confirms the presence of PHB1 in BAECs and mouse aortic and carotid artery lysates via Western blot analysis, supporting its expression in both in vivo and in vitro models. These findings collectively underscore the importance of PHB1 in vascular biology and its potential roles in various cellular processes.",
    "prediction": "The combined analysis of the immunofluorescence images (Fig-1 and Fig-4) and the Western blot (Fig-3) provides a comprehensive understanding of the expression and localization of PHB1 in the vascular system. The immunofluorescence images (Fig-1 and Fig-4) show that PHB1 is predominantly localized in the endothelial cells lining the blood vessels, as indicated by the co-localization with the endothelial marker PECAM-1. This suggests that PHB1 plays a role in endothelial cell function or structure. The Western blot (Fig-3) confirms the presence of PHB1 protein in the endothelial cell lysates, validating the immunofluorescence findings. Additionally, the Western blot shows the presence of actin as a loading control, ensuring the reliability of the protein expression data. Together, these images demonstrate that PHB1 is specifically expressed in endothelial cells within the vascular system, providing insights into its potential role in vascular biology and pathology.",
    "metrics": {
      "bleu1": 0.3767123287671233,
      "bleu2": 0.2497045963756175,
      "bleu3": 0.18233618852402492,
      "bleu4": 0.13124874362614378,
      "rouge-1": 0.359999995,
      "rouge-2": 0.20560747164250165,
      "rouge-l": 0.3333333283333334,
      "em": 0,
      "f1": 0.3466666666666667,
      "precision": 0.3466666666666667,
      "recall": 0.3466666666666667,
      "bertscore_p": 0.6600078344345093,
      "bertscore_r": 0.695855438709259,
      "bertscore_f1": 0.6774576902389526,
      "bertsim": 0.733448326587677,
      "cider": 3.343415875406318e-05
    }
  },
  {
    "id": "19",
    "task": "multisubimageVQA",
    "model": "healthgpt",
    "question": "What key findings from the b-SSFP cine images (Fig-2 and Fig-4) and LGE imaging (Fig-7) help in assessing the severity and progression of the patient's hypertrophic cardiomyopathy?",
    "reference_answer": "The b-SSFP cine images (Fig-2 and Fig-4) reveal a severely dilated left ventricle (LV) with significant systolic dysfunction (LVEF 22%), indicating advanced cardiomyopathy. There is no current LV outflow tract obstruction, but a history of obstructive phenotype ten years ago is noted. The LGE imaging (Fig-7) shows extensive, heterogeneous myocardial fibrosis in the interventricular septum, anterior and inferior LV walls, and papillary muscles of the mitral valve, indicating significant replacement fibrosis and advanced disease progression. These findings collectively suggest severe and progressive HCM, necessitating further clinical evaluation and management.",
    "prediction": "The key findings from the b-SSFP cine images (Fig-2 and Fig-4) and LGE imaging (Fig-7) that help in assessing the severity and progression of the patient's hypertrophic cardiomyopathy are:\n\n1. The b-SSFP cine images (Fig-2 and Fig-4) provide detailed visualization of the myocardial structure and function, allowing for assessment of the extent and distribution of the hypertrophic changes.\n\n2. The LGE imaging (Fig-7) highlights areas of myocardial fibrosis or scarring, which is a common feature of hypertrophic cardiomyopathy and can indicate the severity of the disease.\n\n3. The combination of these imaging modalities allows for a comprehensive evaluation of the structural and functional abnormalities associated with hypertrophic cardiomyopathy, which is crucial for determining the appropriate management and monitoring of the patient's condition.",
    "metrics": {
      "bleu1": 0.3046875,
      "bleu2": 0.1696743058884879,
      "bleu3": 0.12226923682344266,
      "bleu4": 0.09678280624117698,
      "rouge-1": 0.3356643306665363,
      "rouge-2": 0.11518324110413661,
      "rouge-l": 0.3216783166805223,
      "em": 0,
      "f1": 0.27972027972027974,
      "precision": 0.2857142857142857,
      "recall": 0.273972602739726,
      "bertscore_p": 0.6150062084197998,
      "bertscore_r": 0.613530158996582,
      "bertscore_f1": 0.6142672896385193,
      "bertsim": 0.6574641466140747,
      "cider": 2.308181962547008e-07
    }
  },
  {
    "id": "20",
    "task": "multisubimageVQA",
    "model": "healthgpt",
    "question": "How do the images (Fig-1 and Fig-2) demonstrate the impact of improper threshold-based segmentation on the accuracy of tumor contouring?",
    "reference_answer": "The images (Fig-1 and Fig-2) demonstrate that improper threshold-based segmentation, indicated by the small red bounding box, leads to inaccurate tumor contouring. The correct segmentation, shown by the blue VOI, avoids false correlations with adjacent structures such as organs or other tumors, ensuring precise delineation of the lesion. This highlights the critical role of appropriate thresholding in achieving accurate tumor contouring and avoiding misinterpretations.",
    "prediction": "The images (Fig-1 and Fig-2) clearly illustrate the impact of improper threshold-based segmentation on the accuracy of tumor contouring. In Fig-1, the threshold-based segmentation results in an overestimation of the tumor volume, as evidenced by the inclusion of non-tumorous regions within the segmented area. This overestimation can lead to an inaccurate assessment of the tumor's size and shape, potentially affecting treatment planning and outcomes. In contrast, Fig-2 shows a more accurate contouring of the tumor, likely achieved through a more precise segmentation method. This accurate contouring is crucial for effective treatment planning, as it ensures that the entire tumor is targeted while minimizing damage to surrounding healthy tissues. The comparison between these two images highlights the importance of using advanced segmentation techniques to improve the accuracy of tumor contouring in medical imaging.",
    "metrics": {
      "bleu1": 0.2318840579710145,
      "bleu2": 0.14833609386044616,
      "bleu3": 0.08649777178272199,
      "bleu4": 0.05564520501058411,
      "rouge-1": 0.28985506773261926,
      "rouge-2": 0.09890109444451173,
      "rouge-l": 0.26086956048624244,
      "em": 0,
      "f1": 0.30000000000000004,
      "precision": 0.2441860465116279,
      "recall": 0.3888888888888889,
      "bertscore_p": 0.6598954200744629,
      "bertscore_r": 0.6991164684295654,
      "bertscore_f1": 0.6789399981498718,
      "bertsim": 0.861643373966217,
      "cider": 9.802683028691248e-29
    }
  },
  {
    "id": "21",
    "task": "multisubimageVQA",
    "model": "healthgpt",
    "question": "What ultrastructural changes are observed in the microvessels of LDLR mice fed a high cholesterol diet (Fig-1 and Fig-2) compared to LDLR-/- mice fed a low cholesterol diet (Fig-3)?",
    "reference_answer": "In LDLR mice fed a high cholesterol diet (Fig-1 and Fig-2), the ultrastructural changes include severely degenerated microvessels with disrupted endothelial cell integrity, vacuolation, narrowed lumens, and significant lipid deposits. In contrast, LDLR-/- mice fed a low cholesterol diet (Fig-3) exhibit thickened basal laminae, expanded perivascular spaces, and degenerating capillary walls. These differences suggest that high cholesterol diets exacerbate vascular degeneration more severely than low cholesterol diets, even in genetically deficient mice.",
    "prediction": "In the microvessels of LDLR mice fed a high cholesterol diet (Fig-1 and Fig-2), several ultrastructural changes are observed. These include the presence of foam cells, which are macrophages that have ingested large amounts of cholesterol and appear as large, vacuolated cells within the vessel wall. Additionally, there is an accumulation of lipid droplets, which are small, electron-dense particles scattered throughout the vessel wall. In contrast, the microvessels of LDLR-/- mice fed a low cholesterol diet (Fig-3) do not exhibit these changes. The vessel walls in Fig-3 appear normal, without the presence of foam cells or lipid droplets. This comparison highlights the significant impact of a high cholesterol diet on the ultrastructure of microvessels in LDLR mice, leading to the development of atherosclerotic lesions characterized by foam cell formation and lipid accumulation.",
    "metrics": {
      "bleu1": 0.3043478260869566,
      "bleu2": 0.221073231152512,
      "bleu3": 0.17533753207692054,
      "bleu4": 0.14795104482347335,
      "rouge-1": 0.3913043429773157,
      "rouge-2": 0.17582417120154584,
      "rouge-l": 0.36231883573093887,
      "em": 0,
      "f1": 0.3687943262411348,
      "precision": 0.3132530120481928,
      "recall": 0.4482758620689655,
      "bertscore_p": 0.6601508259773254,
      "bertscore_r": 0.7086766958236694,
      "bertscore_f1": 0.6835536360740662,
      "bertsim": 0.8467413187026978,
      "cider": 4.614126851923297e-22
    }
  },
  {
    "id": "22",
    "task": "multisubimageVQA",
    "model": "healthgpt",
    "question": "How do the abdominal X-ray (Fig-1) and ultrasound (Fig-2) contribute to the diagnosis of duodenal obstruction in this case?",
    "reference_answer": "The abdominal X-ray (Fig-1) reveals the double-bubble sign, characterized by gas distention in the stomach and duodenum, suggesting an obstruction. The ultrasound (Fig-2) confirms the presence of pancreatic tissue partially surrounding the duodenum, which is indicative of annular pancreas. Together, these imaging findings provide strong evidence for duodenal obstruction due to annular pancreas, supporting the clinical diagnosis and guiding further management decisions.",
    "prediction": "The abdominal X-ray (Fig-1) and ultrasound (Fig-2) provide complementary information that is crucial for diagnosing duodenal obstruction. The X-ray shows a dilated stomach and proximal duodenum with air-fluid levels, which are classic signs of an obstruction in the gastrointestinal tract. This radiographic evidence suggests that there is a blockage preventing the normal passage of contents through the stomach and duodenum. The ultrasound (Fig-2) further supports this diagnosis by showing a dilated duodenum and the presence of a pancreatic pseudocyst. The pseudocyst is likely exerting pressure on the duodenum, contributing to the obstruction. The combination of these imaging modalities allows for a comprehensive assessment of the patient's condition, confirming the presence of a duodenal obstruction and identifying the underlying cause, which in this case is a pancreatic pseudocyst.",
    "metrics": {
      "bleu1": 0.2932330827067669,
      "bleu2": 0.18852958379112972,
      "bleu3": 0.12384027867489075,
      "bleu4": 0.07352213353097062,
      "rouge-1": 0.42857142375283447,
      "rouge-2": 0.17045454092523257,
      "rouge-l": 0.3968253920068027,
      "em": 0,
      "f1": 0.4307692307692308,
      "precision": 0.358974358974359,
      "recall": 0.5384615384615384,
      "bertscore_p": 0.6868599653244019,
      "bertscore_r": 0.7417172789573669,
      "bertscore_f1": 0.7132354378700256,
      "bertsim": 0.8206382989883423,
      "cider": 3.598970056723673e-26
    }
  },
  {
    "id": "23",
    "task": "multisubimageVQA",
    "model": "healthgpt",
    "question": "What histopathological features are evident in the H&E stained sections of primary colorectal tumor tissues and their corresponding organoid models, and how do these features compare between the two?",
    "reference_answer": "The H&E stained sections of primary colorectal tumor tissues and their corresponding organoid models show several histopathological features. Primary tumor tissues exhibit densely packed cells with hyperchromatic nuclei, nuclear pleomorphism, frequent mitotic figures, and areas of necrosis, indicative of aggressive tumor behavior. Organoids also display similar histopathological features such as glandular structures and inflammatory infiltrates but with more organized cellular architecture compared to the primary tumors. These comparisons suggest that while organoids retain key histopathological features of the original tumors, there are notable differences in cell density and organization that may impact experimental outcomes or therapeutic responses.",
    "prediction": "The H&E stained sections of primary colorectal tumor tissues and their corresponding organoid models reveal several key histopathological features. In the primary tumor tissues, there is a high degree of cellular atypia, characterized by irregularly shaped and sized nuclei, prominent nucleoli, and increased mitotic activity. These features are indicative of malignant transformation and aggressive tumor behavior. In contrast, the organoid models, while also showing cellular atypia, tend to have a more organized structure with less pronounced nuclear pleomorphism and fewer mitotic figures compared to the primary tumors. This suggests that while the organoids retain some of the malignant characteristics of the primary tumors, they may not fully recapitulate the aggressive nature of the original tumor. The comparison highlights the utility of organoid models in studying tumor biology, though with some limitations in mimicking the exact histopathological features of primary tumors.",
    "metrics": {
      "bleu1": 0.4315068493150685,
      "bleu2": 0.3180894785922972,
      "bleu3": 0.24910719168749698,
      "bleu4": 0.2006681767326152,
      "rouge-1": 0.5149700549105384,
      "rouge-2": 0.2600896812363008,
      "rouge-l": 0.47904191119796335,
      "em": 0,
      "f1": 0.5176470588235293,
      "precision": 0.4782608695652174,
      "recall": 0.5641025641025641,
      "bertscore_p": 0.7419458627700806,
      "bertscore_r": 0.7871499061584473,
      "bertscore_f1": 0.7638797163963318,
      "bertsim": 0.8795176148414612,
      "cider": 1.587371109732191e-11
    }
  },
  {
    "id": "24",
    "task": "multisubimageVQA",
    "model": "healthgpt",
    "question": "How do the heterogeneous and high uptake patterns in [68Ga]Ga-ABY-025 PET/CT (Fig-8 and Fig-4) influence the interpretation of treatment response in patients with HER2-positive disease?",
    "reference_answer": "In Fig-8, the heterogeneous uptake pattern suggests varying metabolic activity within the lesions, indicating a mixed response to treatment. Lesions with higher [68Ga]Ga-ABY-025 uptake tend to show better therapeutic responses. In contrast, Fig-4 demonstrates a complete metabolic response in a patient with initially high [68Ga]Ga-ABY-025 uptake (SUVmax, 21), indicating effective treatment. These patterns help in assessing the overall effectiveness of the therapy and guide further clinical decisions.",
    "prediction": "The heterogeneous and high uptake patterns observed in the [68Ga]Ga-ABY-025 PET/CT scans (Fig-8 and Fig-4) are indicative of active HER2-positive disease. These patterns suggest that the tumor cells are expressing high levels of the HER2 receptor, which is a target for trastuzumab therapy. In the context of treatment response, these uptake patterns can be used to monitor the effectiveness of trastuzumab. A decrease in uptake over time would suggest a positive response to the treatment, indicating a reduction in HER2-positive tumor activity. Conversely, persistent or increased uptake could indicate resistance to the therapy or progression of the disease. Therefore, these PET/CT scans are valuable for assessing the biological activity of the tumor and guiding therapeutic decisions.",
    "metrics": {
      "bleu1": 0.29508196721311475,
      "bleu2": 0.1637853271297842,
      "bleu3": 0.06069080709225316,
      "bleu4": 1.4934073779902312e-78,
      "rouge-1": 0.3529411715980511,
      "rouge-2": 0.09248554444184594,
      "rouge-l": 0.3361344489089754,
      "em": 0,
      "f1": 0.3278688524590164,
      "precision": 0.2777777777777778,
      "recall": 0.4,
      "bertscore_p": 0.630964994430542,
      "bertscore_r": 0.6514043807983398,
      "bertscore_f1": 0.6410217881202698,
      "bertsim": 0.488375186920166,
      "cider": 2.41674849581217e-15
    }
  },
  {
    "id": "25",
    "task": "multisubimageVQA",
    "model": "healthgpt",
    "question": "How do the normalized area dynamics and morphology of AS cells compare between those expressing myoIIDN and the control group?",
    "reference_answer": "The normalized area dynamics of AS cells expressing myoIIDN (gray) and the control group (black) show similar fluctuating patterns over a 26-minute period, with no significant differences noted between the groups. The control group (Fig-5) exhibits normal cell morphology and distribution, while the cells expressing myoIIDN (Fig-6) also demonstrate comparable dynamic behavior without marked alterations.",
    "prediction": "Based on the information provided in the image, the normalized area dynamics and morphology of AS cells expressing myoIIDN appear to be similar to those of the control group. The graphs in panels C and D show that the changes in normalized area over time are comparable between the myoIIDN-expressing AS cells and the control AS cells. This suggests that the expression of myoIIDN does not significantly alter the area dynamics or overall morphology of the AS cells compared to the control group.",
    "metrics": {
      "bleu1": 0.33720930232558144,
      "bleu2": 0.23567001437848342,
      "bleu3": 0.17423675969389665,
      "bleu4": 0.1175887110781801,
      "rouge-1": 0.39130434282844995,
      "rouge-2": 0.1818181769687864,
      "rouge-l": 0.3043478210893195,
      "em": 0,
      "f1": 0.3655913978494624,
      "precision": 0.3541666666666667,
      "recall": 0.37777777777777777,
      "bertscore_p": 0.653885006904602,
      "bertscore_r": 0.6473236083984375,
      "bertscore_f1": 0.6505877375602722,
      "bertsim": 0.8948169946670532,
      "cider": 2.5969394656938814e-05
    }
  },
  {
    "id": "26",
    "task": "multisubimageVQA",
    "model": "healthgpt",
    "question": "How do the histological images (Fig-9 and Fig-6) and quantitative data (Fig-10) collectively support the effect of PPARγ modulators on follicular development and maturation in mouse ovaries?",
    "reference_answer": "The histological images (Fig-9 and Fig-6) demonstrate multiple follicles at various developmental stages, indicating successful follicular development and preservation of follicle integrity without significant signs of degeneration. The quantitative data (Fig-10) show significant differences in the number and percentage of follicles between treatment groups, particularly highlighting a higher number of primary follicles and a lower number of primordial follicles in GW9662- and cPA-treated groups compared to the control group. Additionally, the cPA-treated ovaries exhibit a lower ratio of zona pellucida remnants (ZPRs), indicating reduced atresia. Collectively, these findings suggest that PPARγ modulators positively influence follicular development and maturation, promoting the progression from primordial to primary follicles while reducing atresia.",
    "prediction": "The histological images (Fig-9 and Fig-6) and quantitative data (Fig-10) provide a comprehensive view of the effects of PPARγ modulators on follicular development and maturation in mouse ovaries. Fig-9 and Fig-6 show detailed histological sections stained with hematoxylin and eosin, allowing for the visualization of follicular structures at various stages of development. These images reveal differences in follicle size, number, and morphology across different treatment groups, indicating the impact of PPARγ modulators on follicular growth and maturation. The quantitative data in Fig-10 further supports these observations by providing statistical analysis of the number and percentage of follicles at different stages (primordial, primary, secondary, and ZRP) across the treatment groups. The data shows significant variations in follicle counts and maturation stages, highlighting the role of PPARγ modulators in regulating ovarian follicular dynamics. Together, these images and data suggest that PPARγ modulators can influence follicular development and maturation, potentially offering insights into their therapeutic applications in reproductive health.",
    "metrics": {
      "bleu1": 0.36419753086419754,
      "bleu2": 0.24713681343512026,
      "bleu3": 0.1865239517566482,
      "bleu4": 0.14213520980717959,
      "rouge-1": 0.435294112716263,
      "rouge-2": 0.19753085931345166,
      "rouge-l": 0.3999999950692042,
      "em": 0,
      "f1": 0.40697674418604657,
      "precision": 0.36082474226804123,
      "recall": 0.4666666666666667,
      "bertscore_p": 0.6653504371643066,
      "bertscore_r": 0.6645957231521606,
      "bertscore_f1": 0.6649729013442993,
      "bertsim": 0.7891744375228882,
      "cider": 7.749343106645809e-14
    }
  },
  {
    "id": "27",
    "task": "multisubimageVQA",
    "model": "healthgpt",
    "question": "What specific features in the RPE cells of aged Cln3Δex1-6 mice, as shown in Fig-1 and Fig-2, support the hypothesis of impaired autophagic and lysosomal pathways?",
    "reference_answer": "In Fig-1, the presence of numerous electron-dense single-membrane phagosomes containing phagocytosed photoreceptor outer segments (POS) and double membrane-bound vacuolar/autophagosome-like structures in the basal region of the RPE suggests active phagocytic activity and accumulation of autophagosomes. In Fig-2, the detailed visualization of an autophagosome with multiple membranes encapsulating cytoplasmic material further confirms the accumulation of autophagosomes. These features collectively indicate impaired autophagic and lysosomal pathways, contributing to the accumulation of storage material and dysfunctional cellular processes in RPE cells of aged Cln3Δex1-6 mice.",
    "prediction": "The specific features in the RPE cells of aged Cln3Δex1-6 mice, as shown in Fig-1 and Fig-2, that support the hypothesis of impaired autophagic and lysosomal pathways include the presence of numerous autophagic vacuoles (AVs) and multivesicular bodies (MVBs). These structures indicate an accumulation of autophagic and lysosomal components, suggesting a disruption in the normal degradation and recycling processes within the cells.",
    "metrics": {
      "bleu1": 0.4051535512249349,
      "bleu2": 0.25465495421596684,
      "bleu3": 0.17406144222029504,
      "bleu4": 0.12562722106813146,
      "rouge-1": 0.4038461489644971,
      "rouge-2": 0.19259258769163248,
      "rouge-l": 0.28846153357988175,
      "em": 0,
      "f1": 0.4,
      "precision": 0.4666666666666667,
      "recall": 0.35,
      "bertscore_p": 0.7319297790527344,
      "bertscore_r": 0.6648722887039185,
      "bertscore_f1": 0.696791410446167,
      "bertsim": 0.7205123901367188,
      "cider": 0.005745990733611692
    }
  },
  {
    "id": "28",
    "task": "multisubimageVQA",
    "model": "healthgpt",
    "question": "How do the pre-operative (Fig-1) and post-operative (Fig-3) laryngoscopic images reflect the progression and resolution of acute epiglottitis?",
    "reference_answer": "The pre-operative direct laryngoscopic image (Fig-1) shows a severely swollen epiglottis with pus extruding from the aryepiglottic folds, indicative of acute epiglottitis and a high risk of airway obstruction. The post-operative transnasal laryngoscopic image (Fig-3) at Day 7 post-operatively reveals a normal-shaped epiglottis with a clearly visible glottic airway during abduction, indicating successful treatment and resolution of the acute inflammation, ensuring patency of the airway.",
    "prediction": "The pre-operative laryngoscopic image (Fig-1) shows significant inflammation and edema of the epiglottis, which is characteristic of acute epiglottitis. The epiglottis appears swollen and erythematous, indicating a severe inflammatory response. In contrast, the post-operative image (Fig-3) demonstrates a marked reduction in inflammation and edema, with the epiglottis appearing more normal in size and color. This suggests that the treatment was effective in reducing the inflammation and resolving the acute epiglottitis. The absence of significant swelling and erythema in the post-operative image indicates successful management of the condition.",
    "metrics": {
      "bleu1": 0.3586956521739131,
      "bleu2": 0.21748683997289384,
      "bleu3": 0.11638979515809413,
      "bleu4": 0.0648766888200628,
      "rouge-1": 0.3725490146386006,
      "rouge-2": 0.14388488716112022,
      "rouge-l": 0.3333333283640908,
      "em": 0,
      "f1": 0.34951456310679613,
      "precision": 0.32727272727272727,
      "recall": 0.375,
      "bertscore_p": 0.7095907926559448,
      "bertscore_r": 0.7235373258590698,
      "bertscore_f1": 0.7164961695671082,
      "bertsim": 0.8300022482872009,
      "cider": 0.0013827832882741119
    }
  },
  {
    "id": "29",
    "task": "multisubimageVQA",
    "model": "healthgpt",
    "question": "How do the fluorescence imaging characteristics of the bile duct hamartoma (Fig-2) and the focal nodular hyperplasia (Fig-3) help differentiate them from malignant lesions?",
    "reference_answer": "The fluorescence imaging characteristics of the bile duct hamartoma and the focal nodular hyperplasia help differentiate them from malignant lesions through specific patterns. In Fig-2, the bile duct hamartoma shows weak, diffuse fluorescence without a distinctive rim-type pattern, which is indicative of a benign lesion rather than a malignant one. In Fig-3, the focal nodular hyperplasia exhibits near-infrared fluorescence, suggesting the presence of ICG uptake. While this fluorescence indicates some degree of biliary activity, the absence of a rim-type fluorescence pattern further supports the benign nature of the lesion compared to typical malignant lesions.",
    "prediction": "The fluorescence imaging characteristics of the bile duct hamartoma (Fig-2) and the focal nodular hyperplasia (Fig-3) are crucial in differentiating these benign lesions from malignant ones. In Fig-2, the bile duct hamartoma shows no fluorescence, which is a key indicator of its benign nature. Similarly, in Fig-3, the focal nodular hyperplasia also exhibits no fluorescence, further confirming its non-malignant status. Malignant lesions, on the other hand, typically show positive fluorescence due to the presence of cancerous cells that uptake the fluorescent dye. The absence of fluorescence in these images suggests that the lesions are benign and do not exhibit the metabolic activity associated with malignancy. This differentiation is essential for accurate diagnosis and appropriate treatment planning.",
    "metrics": {
      "bleu1": 0.48360655737704916,
      "bleu2": 0.35199318267591256,
      "bleu3": 0.28320656277582684,
      "bleu4": 0.23508273791725132,
      "rouge-1": 0.45390070429254065,
      "rouge-2": 0.24999999507812506,
      "rouge-l": 0.43971630712942006,
      "em": 0,
      "f1": 0.4225352112676056,
      "precision": 0.379746835443038,
      "recall": 0.47619047619047616,
      "bertscore_p": 0.7125413417816162,
      "bertscore_r": 0.7293614149093628,
      "bertscore_f1": 0.7208532691001892,
      "bertsim": 0.95260089635849,
      "cider": 0.00370035015231632
    }
  },
  {
    "id": "30",
    "task": "multisubimageVQA",
    "model": "healthgpt",
    "question": "How do the effects of retinoic acid (RA) treatment on incisor length and color vary when the treatment starts at different embryonic stages (E13.5 and E14.5)?",
    "reference_answer": "The selected sub-images (Fig-3, Fig-4, Fig-7) show that RA treatment beginning at E13.5 results in noticeable reductions in incisor length and lightening of color, whereas treatment starting at E14.5 leads to less severe changes. Specifically, Fig-3 depicts a moderate reduction in length and lightening of color, while Figs-4 and 7 show progressively less severe reductions in size and alterations in pigmentation. This indicates that the severity of the effects decreases as the start of RA treatment is delayed, highlighting the importance of the timing of RA exposure during embryonic development.",
    "prediction": "The effects of retinoic acid (RA) treatment on incisor length and color vary significantly depending on the embryonic stage at which the treatment begins. When RA treatment starts at embryonic day 13.5 (E13.5), there is a noticeable reduction in the length of the incisors compared to the control group. Additionally, the incisors exhibit a yellowish discoloration. In contrast, when RA treatment begins at embryonic day 14.5 (E14.5), the reduction in incisor length is less pronounced, and the yellowish discoloration is not observed. This suggests that the timing of RA exposure is critical, with earlier exposure (E13.5) leading to more severe morphological and color changes in the incisors compared to later exposure (E14.5).",
    "metrics": {
      "bleu1": 0.37398373983739835,
      "bleu2": 0.20716217527962652,
      "bleu3": 0.12104174788437135,
      "bleu4": 0.07373328398035253,
      "rouge-1": 0.38095237595742004,
      "rouge-2": 0.1297297247941565,
      "rouge-l": 0.38095237595742004,
      "em": 0,
      "f1": 0.3492063492063492,
      "precision": 0.3333333333333333,
      "recall": 0.36666666666666664,
      "bertscore_p": 0.6636377573013306,
      "bertscore_r": 0.6692683696746826,
      "bertscore_f1": 0.6664411425590515,
      "bertsim": 0.8411685824394226,
      "cider": 0.0015287824376981293
    }
  },
  {
    "id": "31",
    "task": "multisubimageVQA",
    "model": "healthgpt",
    "question": "What differences in TF expression and nuclear envelope localization are observed in the fluorescence microscopy images (Fig-2, Fig-4, and Fig-5) of tissue sections from control, LPS-, and SAA-treated mice?",
    "reference_answer": "In Fig-2, which uses FITC-conjugated anti-TF antibodies, minimal TF staining is observed in vehicle-treated tissues, while increased TF expression is evident in both LPS- and SAA-treated samples, particularly in the glomeruli and tubular epithelium. In Fig-4 and Fig-5, DAPI staining highlights the nuclear envelope, revealing increased fluorescence intensity in response to LPS and SAA treatments compared to controls. These findings suggest that SAA and LPS treatments induce TF accumulation and cellular activity, particularly in the glomeruli and tubular epithelium.",
    "prediction": "In the fluorescence microscopy images (Fig-2, Fig-4, and Fig-5) of tissue sections from control, LPS-, and SAA-treated mice, several differences in TF expression and nuclear envelope localization are observed. In the control group (Fig-2), TF expression is minimal, with only a few cells showing weak fluorescence. In contrast, the LPS-treated group (Fig-4) shows a significant increase in TF expression, with numerous cells exhibiting strong fluorescence. This indicates a robust upregulation of TF in response to LPS treatment. Similarly, the SAA-treated group (Fig-5) also demonstrates a marked increase in TF expression, comparable to the LPS-treated group, suggesting that SAA induces a similar upregulation of TF. Additionally, in both the LPS- and SAA-treated groups, TF is prominently localized to the nuclear envelope, as indicated by the arrows in the images. This nuclear envelope localization is less pronounced in the control group. These observations suggest that both LPS and SAA treatments lead to a significant upregulation and nuclear envelope localization of TF, which may play a role in the cellular response to these treatments.",
    "metrics": {
      "bleu1": 0.2569832402234637,
      "bleu2": 0.16562244807015666,
      "bleu3": 0.10275139442360016,
      "bleu4": 0.059254334553685874,
      "rouge-1": 0.31944443983024695,
      "rouge-2": 0.1552511371389255,
      "rouge-l": 0.27777777316358027,
      "em": 0,
      "f1": 0.29530201342281875,
      "precision": 0.2268041237113402,
      "recall": 0.4230769230769231,
      "bertscore_p": 0.6391093730926514,
      "bertscore_r": 0.6847043037414551,
      "bertscore_f1": 0.661121666431427,
      "bertsim": 0.6022490859031677,
      "cider": 9.634759592545453e-52
    }
  },
  {
    "id": "32",
    "task": "multisubimageVQA",
    "model": "healthgpt",
    "question": "How does the progression of acute macular neuroretinopathy (AMN) manifest in the selected SD-OCT images (Fig-1, Fig-2, and Fig-3)?",
    "reference_answer": "The progression of AMN is evident in the selected SD-OCT images. Fig-1 shows a hyperreflective band extending outward from the outer plexiform layer during the acute phase. By day 4 (Fig-2), there is disruption in the outer retinal layers, indicating significant photoreceptor damage. At day 45 (Fig-3), the outer retinal layers show substantial thinning and disruption, suggesting ongoing retinal pathology that could impact visual acuity.",
    "prediction": "The progression of acute macular neuroretinopathy (AMN) in the selected SD-OCT images can be observed through distinct changes in the retinal structure over time. In Fig-1 (Day 1), the retinal layers appear relatively normal with no significant abnormalities. By Day 4, as shown in Fig-2, there is a noticeable disruption in the outer retinal layers, indicating the onset of AMN. This disruption is characterized by irregularities and potential thinning of the layers. By Day 45, depicted in Fig-3, the outer retinal layers have further deteriorated, showing more pronounced irregularities and thinning. These changes suggest a progressive degeneration of the retinal structure, which is consistent with the typical progression of AMN. The images highlight the importance of early detection and monitoring of retinal changes to manage and potentially mitigate the effects of AMN.",
    "metrics": {
      "bleu1": 0.2805755395683453,
      "bleu2": 0.19654507267480198,
      "bleu3": 0.15418745336955875,
      "bleu4": 0.11719971606335436,
      "rouge-1": 0.3582089504421921,
      "rouge-2": 0.16853932137356406,
      "rouge-l": 0.3432835773078637,
      "em": 0,
      "f1": 0.3235294117647059,
      "precision": 0.26506024096385544,
      "recall": 0.41509433962264153,
      "bertscore_p": 0.6978269815444946,
      "bertscore_r": 0.7547996044158936,
      "bertscore_f1": 0.7251960039138794,
      "bertsim": 0.8429012298583984,
      "cider": 1.3849651898517276e-27
    }
  },
  {
    "id": "33",
    "task": "multisubimageVQA",
    "model": "healthgpt",
    "question": "What common characteristics can be observed in the necrosuppurative lesions of the liver and uterus as depicted in Fig-2 and Fig-4?",
    "reference_answer": "Both the liver and uterine lesions in Fig-2 and Fig-4 exhibit central areas of necrosis surrounded by abundant intralesional colonies of bacterial rods and variable numbers of degenerated neutrophils. These features suggest a severe inflammatory response consistent with an active bacterial infection in both organs.",
    "prediction": "The necrosuppurative lesions in both the liver and uterus, as shown in Fig-2 and Fig-4, exhibit several common histopathological features. These include the presence of necrotic tissue, which is characterized by the loss of normal cellular architecture and the presence of cellular debris. Additionally, there is a significant infiltration of inflammatory cells, predominantly neutrophils, which are indicative of an acute inflammatory response. The lesions also show areas of suppuration, where pus formation occurs due to the accumulation of dead neutrophils, bacteria, and tissue debris. These features suggest a severe infectious or inflammatory process affecting both organs, leading to tissue damage and necrosis.",
    "metrics": {
      "bleu1": 0.2616822429906542,
      "bleu2": 0.18590805705512317,
      "bleu3": 0.13207939015393044,
      "bleu4": 0.09702484425077929,
      "rouge-1": 0.37037036580932786,
      "rouge-2": 0.1818181775578269,
      "rouge-l": 0.35185184729080937,
      "em": 0,
      "f1": 0.33027522935779813,
      "precision": 0.2535211267605634,
      "recall": 0.47368421052631576,
      "bertscore_p": 0.6644308567047119,
      "bertscore_r": 0.7731078863143921,
      "bertscore_f1": 0.7146614789962769,
      "bertsim": 0.7214860916137695,
      "cider": 2.1930770512338896e-20
    }
  },
  {
    "id": "34",
    "task": "multisubimageVQA",
    "model": "healthgpt",
    "question": "How do the measurements depicted in Fig-1 and Fig-2 contribute to the assessment of patellar alignment and potential instability?",
    "reference_answer": "In Fig-1, Line 1 is drawn through the deepest cartilaginous point of the trochlear groove, forming a 90° angle with the posterior condylar line. This establishes a reference point for the trochlear groove. In Fig-2, Line 2 is drawn in parallel to Line 1 from the center of the patellar tendon, extending to the original posterior condylar line. The distance between these two lines represents the TT-TG distance. This measurement provides crucial information on the alignment between the tibial tubercle and the trochlear groove, helping to identify any potential patellar instability or tracking abnormalities.",
    "prediction": "The measurements depicted in Fig-1 and Fig-2 are crucial for assessing patellar alignment and potential instability. In Fig-1, the patellar tilt angle (PTA) is measured, which helps in determining the degree of lateral or medial tilt of the patella relative to the femoral condyles. An abnormal PTA can indicate patellar malalignment, which is often associated with patellofemoral pain syndrome or instability. In Fig-2, the Insall-Salvati ratio (ISR) is calculated by dividing the length of the patellar tendon by the length of the patella. This ratio is used to assess patellar height; a ratio greater than 1.2 suggests patella alta (high-riding patella), while a ratio less than 0.8 indicates patella baja (low-riding patella). Both conditions can contribute to patellar instability. By analyzing these measurements, clinicians can better understand the biomechanical factors contributing to patellar instability and develop appropriate treatment plans.",
    "metrics": {
      "bleu1": 0.2972972972972973,
      "bleu2": 0.1349143259432907,
      "bleu3": 0.06294063090534824,
      "bleu4": 1.5347386375739774e-78,
      "rouge-1": 0.28947367943213304,
      "rouge-2": 0.05581394870740982,
      "rouge-l": 0.23684210048476464,
      "em": 0,
      "f1": 0.2597402597402597,
      "precision": 0.21739130434782608,
      "recall": 0.3225806451612903,
      "bertscore_p": 0.5879321098327637,
      "bertscore_r": 0.6248639822006226,
      "bertscore_f1": 0.6058357357978821,
      "bertsim": 0.6278340220451355,
      "cider": 1.7282359781714905e-13
    }
  },
  {
    "id": "35",
    "task": "multisubimageVQA",
    "model": "healthgpt",
    "question": "What specific imaging characteristics of the masses in Fig-1 and Fig-2 suggest potential malignancy, and how do these characteristics differ between the arterial and portal phases?",
    "reference_answer": "In Fig-1, the 3.6×4.8 cm mass in segment 6 of the liver during the arterial phase exhibits heterogeneous enhancement and irregular margins, which are suggestive of hepatocellular carcinoma (HCC). In Fig-2, the 3.3×2.6 cm mass at the porta hepatis and the portion of the segment 6 mass during the portal phase show continued enhancement, indicating persistent abnormality. The heterogeneous enhancement and irregular margins in the arterial phase (Fig-1) are more indicative of HCC, whereas the portal phase (Fig-2) shows ongoing enhancement, consistent with malignancy but without the distinct arterial phase characteristics.",
    "prediction": "The masses in Fig-1 and Fig-2 exhibit several imaging characteristics that suggest potential malignancy. In the arterial phase (Fig-1), the masses show heterogeneous enhancement, which is a common feature of malignant tumors due to their irregular vascular supply. In the portal phase (Fig-2), the masses appear hypodense compared to the surrounding liver parenchyma, indicating areas of necrosis or cystic degeneration within the tumor. These differences in enhancement patterns between the arterial and portal phases help in assessing the tumor's vascularity and internal structure, which are crucial for diagnosis and treatment planning.",
    "metrics": {
      "bleu1": 0.3875657840749332,
      "bleu2": 0.17877076548665505,
      "bleu3": 0.09996291554223236,
      "bleu4": 0.05695129296310725,
      "rouge-1": 0.29032257569198755,
      "rouge-2": 0.07185628242963209,
      "rouge-l": 0.22580644665972954,
      "em": 0,
      "f1": 0.2622950819672131,
      "precision": 0.23529411764705882,
      "recall": 0.2962962962962963,
      "bertscore_p": 0.6126565933227539,
      "bertscore_r": 0.5997418165206909,
      "bertscore_f1": 0.6061304211616516,
      "bertsim": 0.7829867601394653,
      "cider": 1.3479551909383463
    }
  },
  {
    "id": "36",
    "task": "multisubimageVQA",
    "model": "healthgpt",
    "question": "How do the CT images (Fig-1, Fig-2, Fig-3) demonstrate the progression of ischemic changes in the brain following a perioperative stroke?",
    "reference_answer": "The CT images show a clear progression of ischemic changes in the brain. Fig-1 initially reveals a slight hypodensity in the right frontal and insular cortex, indicating early ischemic changes. Fig-2, taken after recanalization, shows a more pronounced low density in the same regions, suggesting ongoing ischemia despite the intervention. Fig-3, taken seven days later, demonstrates ischemic edema in the frontal operculum and temporal pole, indicating the evolution and expansion of the ischemic area over time. These images collectively provide evidence of the progression from early ischemic changes to more extensive edema, reflecting the ongoing nature of the ischemic process.",
    "prediction": "The CT images (Fig-1, Fig-2, Fig-3) illustrate the progression of ischemic changes in the brain following a perioperative stroke. In Fig-1, the initial CT scan shows a hypodense area in the left basal ganglia, indicative of an acute ischemic stroke. This hypodensity suggests a lack of blood flow and subsequent tissue damage in that region. In Fig-2, the follow-up CT scan reveals an increase in the size of the hypodense area, indicating that the ischemic damage has worsened over time. This progression is consistent with the natural course of an untreated ischemic stroke, where the affected brain tissue continues to deteriorate. Finally, in Fig-3, the CT scan shows a further increase in the size of the hypodense area, demonstrating continued progression of the ischemic changes. This series of images highlights the importance of timely intervention in stroke management to prevent further brain damage and improve patient outcomes.",
    "metrics": {
      "bleu1": 0.34415584415584416,
      "bleu2": 0.22245552645678893,
      "bleu3": 0.14309631173344411,
      "bleu4": 0.09386249432422449,
      "rouge-1": 0.3076923027336301,
      "rouge-2": 0.11981566334812821,
      "rouge-l": 0.2797202747616021,
      "em": 0,
      "f1": 0.2876712328767123,
      "precision": 0.2625,
      "recall": 0.3181818181818182,
      "bertscore_p": 0.66713947057724,
      "bertscore_r": 0.7098185420036316,
      "bertscore_f1": 0.6878175735473633,
      "bertsim": 0.7174050807952881,
      "cider": 6.71556391128532e-14
    }
  },
  {
    "id": "37",
    "task": "multisubimageVQA",
    "model": "healthgpt",
    "question": "How do the visualizations in Fig-1, Fig-3, and Fig-4 differ in terms of stent strut detection and guidewire navigation, and what implications do these differences have for clinical decision-making?",
    "reference_answer": "In Fig-1 and Fig-3, all three imaging systems agree on the visualization of the guidewire rewiring into a side branch and the presence of undetected stent struts. These images show consistent findings, which support the reliability of the imaging systems in identifying the guidewire and potential undetected stent struts. In contrast, Fig-4 illustrates a case of disagreement, where version 1.1 fails to detect the stent struts adequately, while version 1.2 and the offline 3D system provide clearer visualization. This difference highlights the improved performance of version 1.2 in detecting stent struts, which is crucial for accurate clinical decision-making and ensuring optimal stent placement. The enhanced visualization in version 1.2 and the offline 3D system reduces the risk of missing critical details that could lead to complications such as restenosis or thrombosis.",
    "prediction": "The visualizations in Fig-1, Fig-3, and Fig-4 differ significantly in their ability to detect stent struts and navigate guidewires. In Fig-1, the stent struts are clearly visible, allowing for precise navigation of the guidewire. This clarity is crucial for accurate placement and assessment of the stent. In contrast, Fig-3 and Fig-4 show poor visualization of the stent struts, making it challenging to navigate the guidewire effectively. This lack of clarity can lead to difficulties in ensuring proper stent deployment and may increase the risk of complications. Clinically, these differences highlight the importance of high-quality imaging for successful stent placement and the potential need for alternative imaging techniques or technologies to improve visualization in cases where current methods fall short.",
    "metrics": {
      "bleu1": 0.4682939905866591,
      "bleu2": 0.2714576726072249,
      "bleu3": 0.15493895093039942,
      "bleu4": 0.07211102457574041,
      "rouge-1": 0.3797468304558565,
      "rouge-2": 0.15044247288237156,
      "rouge-l": 0.354430374759654,
      "em": 0,
      "f1": 0.345679012345679,
      "precision": 0.36363636363636365,
      "recall": 0.32941176470588235,
      "bertscore_p": 0.6785130500793457,
      "bertscore_r": 0.6624151468276978,
      "bertscore_f1": 0.6703674793243408,
      "bertsim": 0.9211980700492859,
      "cider": 0.1554781415897607
    }
  },
  {
    "id": "38",
    "task": "multisubimageVQA",
    "model": "healthgpt",
    "question": "What do the IHC staining patterns in the tumor spheres formed by ALDHhigh and ALDHlow SiHa cells (Fig-5, Fig-3, and Fig-7) reveal about the expression levels of stem cell-associated transcription factors?",
    "reference_answer": "The IHC staining patterns in the tumor spheres formed by ALDHhigh and ALDHlow SiHa cells reveal differential expression levels of stem cell-associated transcription factors. In ALDHhigh cells, there is notable brown nuclear staining, indicating higher expression levels of these markers, whereas ALDHlow cells exhibit lower or absent staining. This differential expression supports the idea that ALDHhigh cells possess higher stemness characteristics, which may be significant for tumor progression and therapeutic resistance.",
    "prediction": "The IHC staining patterns in the tumor spheres formed by ALDHhigh and ALDHlow SiHa cells (Fig-5, Fig-3, and Fig-7) reveal significant differences in the expression levels of stem cell-associated transcription factors. In Fig-5, the ALDHhigh SiHa cells show strong nuclear staining for OCT4, NANOG, KLF4, and BMI1, indicating high expression levels of these transcription factors, which are crucial for maintaining stemness and self-renewal properties. Conversely, the ALDHlow SiHa cells exhibit much weaker staining, suggesting lower expression levels of these factors. Similarly, in Fig-3 and Fig-7, the ALDHhigh SiHa cells demonstrate robust nuclear staining for OCT4, NANOG, KLF4, and BMI1, while the ALDHlow SiHa cells show minimal staining. These observations suggest that ALDHhigh SiHa cells possess a higher stem cell-like phenotype compared to ALDHlow SiHa cells, as evidenced by the elevated expression of key stem cell-associated transcription factors.",
    "metrics": {
      "bleu1": 0.3732394366197183,
      "bleu2": 0.27706598110617087,
      "bleu3": 0.22934380764315684,
      "bleu4": 0.20151155951635488,
      "rouge-1": 0.5538461489893491,
      "rouge-2": 0.2873563171033162,
      "rouge-l": 0.4769230720662722,
      "em": 0,
      "f1": 0.5606060606060606,
      "precision": 0.4805194805194805,
      "recall": 0.6727272727272727,
      "bertscore_p": 0.6837759017944336,
      "bertscore_r": 0.803406298160553,
      "bertscore_f1": 0.7387794852256775,
      "bertsim": 0.8575240969657898,
      "cider": 1.2738336948819865e-26
    }
  },
  {
    "id": "39",
    "task": "multisubimageVQA",
    "model": "healthgpt",
    "question": "What morphological changes are observed in the murine B16F10 cells in Fig-2 and Fig-3, and how do these changes relate to the treatment with cirsimaritin?",
    "reference_answer": "In both Fig-2 and Fig-3, the murine B16F10 cells exhibit an increase in dendritic branching, characterized by abundant and well-defined dendrites extending from the cell bodies. These morphological changes suggest that the treatment with cirsimaritin promotes dendritogenesis, leading to the formation of a more complex network of dendrites. This observation supports the role of cirsimaritin in inducing early stages of melanogenesis, as evidenced by the enhanced dendritic structures in the cells.",
    "prediction": "In Fig-2, the murine B16F10 cells treated with cirsimaritin at a concentration of 6.25 μM exhibit significant morphological changes, including cell shrinkage, membrane blebbing, and the formation of apoptotic bodies. These changes are indicative of apoptosis, a programmed cell death process. In Fig-3, the cells treated with cirsimaritin at a higher concentration of 12.5 μM show even more pronounced apoptotic features, such as increased cell shrinkage, more extensive membrane blebbing, and a higher number of apoptotic bodies. These observations suggest that cirsimaritin induces apoptosis in a dose-dependent manner, with higher concentrations leading to more severe apoptotic changes. This indicates that cirsimaritin has a potent pro-apoptotic effect on B16F10 cells, which could be relevant for its potential use in cancer therapy.",
    "metrics": {
      "bleu1": 0.30708661417322836,
      "bleu2": 0.17799870661764738,
      "bleu3": 0.10046031999840715,
      "bleu4": 0.05347373218224803,
      "rouge-1": 0.3759398448301205,
      "rouge-2": 0.12429378052922231,
      "rouge-l": 0.3759398448301205,
      "em": 0,
      "f1": 0.373134328358209,
      "precision": 0.31645569620253167,
      "recall": 0.45454545454545453,
      "bertscore_p": 0.6500615477561951,
      "bertscore_r": 0.7070302367210388,
      "bertscore_f1": 0.6773501634597778,
      "bertsim": 0.5622183680534363,
      "cider": 2.708553605246954e-15
    }
  },
  {
    "id": "40",
    "task": "multisubimageVQA",
    "model": "healthgpt",
    "question": "How do the expressions of TGF-β1 and TGF-β2 mRNAs differ between the infarct area and the surrounding brain regions, as shown in Fig-1 and Fig-6?",
    "reference_answer": "In Fig-1, TGF-β1 mRNA expression is highly induced both at the perimeter of the lesion and within the infarct area 72 hours post-MCAO, with significant accumulation noted in the corpus callosum. In contrast, Fig-6 shows that TGF-β2 mRNA is present in only a few cells at the perimeter of the infarct area, while maintaining a normal distribution in the cerebral cortex outside the lesion. This suggests that TGF-β1 has a more extensive and pronounced upregulation response compared to TGF-β2, potentially indicating distinct roles in tissue repair mechanisms post-ischemic injury.",
    "prediction": "The expressions of TGF-β1 and TGF-β2 mRNAs differ significantly between the infarct area and the surrounding brain regions. In Fig-1, TGF-β1 mRNA is highly expressed in the infarct area, indicating a strong response to the ischemic injury. In contrast, Fig-6 shows that TGF-β2 mRNA is also expressed in the infarct area but to a lesser extent compared to TGF-β1. The surrounding brain regions exhibit lower levels of both TGF-β1 and TGF-β2 mRNAs. This differential expression suggests that TGF-β1 may play a more prominent role in the immediate response to ischemic injury, while TGF-β2 might be involved in later stages of the response or in different aspects of the healing process.",
    "metrics": {
      "bleu1": 0.4608695652173913,
      "bleu2": 0.3242076535084268,
      "bleu3": 0.22348571885672663,
      "bleu4": 0.16252019563771936,
      "rouge-1": 0.4496123981010757,
      "rouge-2": 0.22857142359902052,
      "rouge-l": 0.4186046461630912,
      "em": 0,
      "f1": 0.43609022556390975,
      "precision": 0.43283582089552236,
      "recall": 0.4393939393939394,
      "bertscore_p": 0.6955253481864929,
      "bertscore_r": 0.6869404315948486,
      "bertscore_f1": 0.6912062168121338,
      "bertsim": 0.8931577205657959,
      "cider": 0.003475870586003539
    }
  },
  {
    "id": "41",
    "task": "multisubimageVQA",
    "model": "healthgpt",
    "question": "How do the clinical, dermoscopic, and RCM findings (Fig-1, Fig-2, and Fig-3) contribute to the diagnosis and characterization of melanoma in situ?",
    "reference_answer": "The clinical and dermoscopic findings (Fig-1) reveal a tan to dark brown patch with an atypical network, indicative of melanocytic proliferation. The RCM mosaic image (Fig-2) shows large, bright cells and dendritic processes in the upper epidermis, supporting the presence of Pagetoid spread of melanocytes. The higher magnification RCM image (Fig-3) demonstrates large, bright, nucleated cells with pleomorphic characteristics and a disarranged pattern, consistent with melanoma in situ. Collectively, these findings provide strong evidence for the diagnosis of melanoma in situ and characterize the extent of cellular abnormalities and architectural disruption.",
    "prediction": "The clinical, dermoscopic, and RCM findings collectively provide a comprehensive understanding of melanoma in situ. The clinical image (Fig-1) shows the macroscopic appearance of the lesion, which is crucial for initial identification and assessment. The dermoscopic image (Fig-2) offers a closer look at the surface patterns and structures, revealing asymmetry, irregular borders, and varied pigmentation, which are key indicators of melanoma. The RCM image (Fig-3) provides a detailed view of the cellular architecture, showing atypical melanocytes with irregular shapes and sizes, which are definitive for diagnosing melanoma in situ. Together, these images allow for a thorough evaluation of the lesion, confirming the presence of melanoma in situ and aiding in the decision-making process for appropriate treatment.",
    "metrics": {
      "bleu1": 0.4049586776859504,
      "bleu2": 0.23951857131652576,
      "bleu3": 0.15682205367037602,
      "bleu4": 0.09950964216216275,
      "rouge-1": 0.3453237360281559,
      "rouge-2": 0.12435232664501081,
      "rouge-l": 0.33093524681952285,
      "em": 0,
      "f1": 0.3380281690140845,
      "precision": 0.3157894736842105,
      "recall": 0.36363636363636365,
      "bertscore_p": 0.6817824840545654,
      "bertscore_r": 0.691641092300415,
      "bertscore_f1": 0.6866764426231384,
      "bertsim": 0.8820925354957581,
      "cider": 0.00019878687400908397
    }
  },
  {
    "id": "42",
    "task": "multisubimageVQA",
    "model": "healthgpt",
    "question": "How do the different stages of hemorrhage (Fig-2) and edema (Fig-5) correlate with the severity of lung injury?",
    "reference_answer": "The different stages of hemorrhage and edema in the selected sub-images (Fig-2 and Fig-5) directly correlate with the severity of lung injury. In Fig-2, the stages range from absent hemorrhage (A) to severe diffuse massive infiltrate (D), indicating increasing levels of bleeding. In Fig-5, the stages progress from absent edema (A) to abundant edema entirely filling the alveoli in more than 50% of the lung section (D), indicating increasing fluid accumulation. Both pathologies reflect the extent of lung injury, with higher stages suggesting more severe damage and potential impairment of gas exchange.",
    "prediction": "The different stages of hemorrhage and edema depicted in the images correlate directly with the severity of lung injury. In Fig-2, the progression from no hemorrhage (Fig-2A) to severe hemorrhage (Fig-2D) indicates an increasing severity of lung damage. Similarly, in Fig-5, the transition from no edema (Fig-5A) to severe edema (Fig-5D) reflects a worsening of lung injury. The images show that as the severity of hemorrhage and edema increases, there is a corresponding increase in the disruption of alveolar architecture and the presence of inflammatory cells. This suggests that both hemorrhage and edema are critical indicators of the extent of lung injury, with more severe stages associated with greater tissue damage and inflammation.",
    "metrics": {
      "bleu1": 0.4745762711864407,
      "bleu2": 0.330934436169802,
      "bleu3": 0.25709846240919826,
      "bleu4": 0.2132711733618986,
      "rouge-1": 0.4166666616791667,
      "rouge-2": 0.2762430889411191,
      "rouge-l": 0.39999999501250005,
      "em": 0,
      "f1": 0.4132231404958677,
      "precision": 0.390625,
      "recall": 0.43859649122807015,
      "bertscore_p": 0.7415116429328918,
      "bertscore_r": 0.748031735420227,
      "bertscore_f1": 0.7447574138641357,
      "bertsim": 0.8757848739624023,
      "cider": 0.004633561018610872
    }
  },
  {
    "id": "43",
    "task": "multisubimageVQA",
    "model": "healthgpt",
    "question": "How do the ROIs in the control pedunculated tubular adenoma (Fig-1) and the pedunculated T1 colorectal cancer (Fig-2) differ in terms of their molecular profiles, specifically regarding proliferation rates (Ki-67 staining) and structural integrity (pan-cytokeratin staining)?",
    "reference_answer": "The ROIs in the control pedunculated tubular adenoma (Fig-1) show lower proliferation rates indicated by Ki-67 staining compared to those in the pedunculated T1 colorectal cancer (Fig-2). Additionally, the structural integrity, as shown by pan-cytokeratin staining, is more uniform and less disrupted in the control adenoma than in the cancerous tissue. These differences suggest that the control adenoma has fewer proliferating cells and better-preserved cellular architecture, consistent with its benign nature, whereas the T1 colorectal cancer exhibits increased cell proliferation and more irregular structural features, indicative of malignancy.",
    "prediction": "The ROIs in the control pedunculated tubular adenoma (Fig-1) and the pedunculated T1 colorectal cancer (Fig-2) show distinct differences in their molecular profiles. In the control adenoma, the Ki-67 staining is relatively low, indicating a lower proliferation rate, and the pan-cytokeratin staining shows well-preserved structural integrity of the epithelial cells. Conversely, in the T1 colorectal cancer, the Ki-67 staining is significantly higher, reflecting a higher proliferation rate, and the pan-cytokeratin staining reveals disrupted structural integrity, indicative of malignant transformation. These differences highlight the progression from a benign adenoma to a malignant carcinoma, with increased cellular proliferation and loss of normal epithelial architecture.",
    "metrics": {
      "bleu1": 0.5188679245283019,
      "bleu2": 0.3514825486856326,
      "bleu3": 0.25525097523698903,
      "bleu4": 0.19524363234045958,
      "rouge-1": 0.5196850343703889,
      "rouge-2": 0.23952095309835428,
      "rouge-l": 0.4094488138979478,
      "em": 0,
      "f1": 0.4881889763779527,
      "precision": 0.49206349206349204,
      "recall": 0.484375,
      "bertscore_p": 0.7288755178451538,
      "bertscore_r": 0.7563859224319458,
      "bertscore_f1": 0.7423759698867798,
      "bertsim": 0.9410693049430847,
      "cider": 0.15359805262108994
    }
  },
  {
    "id": "44",
    "task": "multisubimageVQA",
    "model": "healthgpt",
    "question": "What are the key differences in the banding patterns and interactions between *C. albicans* and *S. aureus* at the initial stage (t=0 hours) and after 9 and 12 hours post-inoculation as depicted in the selected sub-images?",
    "reference_answer": "At the initial stage (t=0 hours), the biofilm consists of uniformly small, round cells with no distinct banding patterns, indicating minimal cellular diversity and early-stage biofilm development (Fig-2). After 9 hours post-inoculation, a serrated interface is observed between the *C. albicans* and *S. aureus* bands, with *C. albicans* hyphae penetrating the *S. aureus* band (Fig-6). By 12 hours post-inoculation, distinct banding patterns emerge: a peripheral band of *S. aureus*, a middle band of *C. albicans*, and an internal discontinuous band of *S. aureus* (Fig-3). These observations highlight the evolution of spatial organization and interaction between the two species over time.",
    "prediction": "The key differences in the banding patterns and interactions between *C. albicans* and *S. aureus* at the initial stage (t=0 hours) and after 9 and 12 hours post-inoculation, as depicted in the selected sub-images, are as follows: At t=0 hours, *C. albicans* and *S. aureus* exhibit distinct and separate banding patterns with minimal interaction. By 9 hours post-inoculation, there is a noticeable increase in the interaction between the two species, with *C. albicans* bands becoming more intertwined with *S. aureus* bands, indicating the beginning of co-colonization. At 12 hours post-inoculation, the interaction is even more pronounced, with *C. albicans* and *S. aureus* forming a more integrated and complex banding pattern, suggesting a higher level of co-colonization and potential biofilm formation. These changes highlight the dynamic nature of microbial interactions and the progression of co-colonization over time.",
    "metrics": {
      "bleu1": 0.4797297297297297,
      "bleu2": 0.3331034323932769,
      "bleu3": 0.23916224510197912,
      "bleu4": 0.17070179700868948,
      "rouge-1": 0.4755244705364565,
      "rouge-2": 0.19512194629387283,
      "rouge-l": 0.4615384565504426,
      "em": 0,
      "f1": 0.4689655172413793,
      "precision": 0.44155844155844154,
      "recall": 0.5,
      "bertscore_p": 0.6908669471740723,
      "bertscore_r": 0.7021505832672119,
      "bertscore_f1": 0.6964631080627441,
      "bertsim": 0.858624279499054,
      "cider": 3.228333783834785e-08
    }
  },
  {
    "id": "45",
    "task": "multisubimageVQA",
    "model": "healthgpt",
    "question": "What changes in the omental metastases and peri-portal lymphadenopathy are observed between the CT scans taken after cycle 3 (Fig-1) and cycle 6 (Fig-2)?",
    "reference_answer": "Between the CT scans taken after cycle 3 (Fig-1) and cycle 6 (Fig-2), there is a marked reduction in omental metastases and peri-portal lymphadenopathy. Fig-1 shows extensive omental carcinomatosis and mesenteric metastases, along with significant peri-portal lymphadenopathy. In contrast, Fig-2 demonstrates a decrease in the size and number of omental metastases and reduced peri-portal lymphadenopathy, indicating a positive response to the CAPOX-B treatment regimen.",
    "prediction": "Between the CT scans taken after cycle 3 (Fig-1) and cycle 6 (Fig-2), there is a significant reduction in the size of the omental metastases and peri-portal lymphadenopathy. In Fig-1, the omental metastases and peri-portal lymphadenopathy are clearly visible, indicating the presence of metastatic disease. However, in Fig-2, taken after cycle 6, the size of these lesions has decreased, suggesting a positive response to the treatment. This reduction in the size of the metastatic lesions and lymphadenopathy indicates that the treatment has been effective in controlling the disease progression.",
    "metrics": {
      "bleu1": 0.4838709677419355,
      "bleu2": 0.4037864265436242,
      "bleu3": 0.3503411036031212,
      "bleu4": 0.30867118779729363,
      "rouge-1": 0.5918367297022075,
      "rouge-2": 0.40601503264175476,
      "rouge-l": 0.5918367297022075,
      "em": 0,
      "f1": 0.5742574257425743,
      "precision": 0.5370370370370371,
      "recall": 0.6170212765957447,
      "bertscore_p": 0.7735821008682251,
      "bertscore_r": 0.7976495027542114,
      "bertscore_f1": 0.785431444644928,
      "bertsim": 0.9065828323364258,
      "cider": 0.0006191487613678978
    }
  },
  {
    "id": "46",
    "task": "multisubimageVQA",
    "model": "healthgpt",
    "question": "How do the CT and MRI images (Fig-1 and Fig-2) help differentiate between scar tissue and potential tumor recurrence in the postoperative changes of the patient's neck?",
    "reference_answer": "The CT scan (Fig-1) shows postoperative changes with an intermediate density tissue in the infratemporal fossa near the right pterygoid process, indicating uncertainty between scar tissue and tumor recurrence. The MRI scan (Fig-2), taken one month later, reveals a larger lesion in the floor of the mouth, measuring 1.9 x 3.5 x 3.9 cm, which is inseparable from the right mylohyoid muscle and other floor of mouth muscles. The rapid growth of the lesion over this period suggests a higher likelihood of tumor recurrence rather than scar tissue formation, although definitive diagnosis would require further clinical evaluation and possibly biopsy.",
    "prediction": "The CT and MRI images (Fig-1 and Fig-2) are crucial in differentiating between scar tissue and potential tumor recurrence in the postoperative changes of the patient's neck. The CT scan (Fig-1) provides a detailed view of the bony structures and soft tissues, allowing for the identification of any irregularities or masses that could indicate tumor recurrence. The MRI scan (Fig-2) offers superior soft tissue contrast, which is essential for distinguishing between scar tissue and residual or recurrent tumor. Scar tissue typically appears as a well-defined, homogeneous area with low signal intensity on T1-weighted images and high signal intensity on T2-weighted images. In contrast, tumor recurrence may present as a heterogeneous mass with irregular borders and varying signal intensities on both T1 and T2-weighted images. Additionally, the use of contrast agents in MRI can further enhance the differentiation by highlighting areas of increased vascularity, which are more likely to be associated with tumor recurrence rather than scar tissue. These imaging modalities, when used together, provide a comprehensive assessment of the postoperative changes, aiding in the accurate diagnosis and management of the patient's condition.",
    "metrics": {
      "bleu1": 0.24867724867724864,
      "bleu2": 0.17442270615742783,
      "bleu3": 0.12498231365645082,
      "bleu4": 0.09572616945852339,
      "rouge-1": 0.24598929998798938,
      "rouge-2": 0.1322957151841816,
      "rouge-l": 0.21390373849066327,
      "em": 0,
      "f1": 0.25130890052356014,
      "precision": 0.20869565217391303,
      "recall": 0.3157894736842105,
      "bertscore_p": 0.5789135694503784,
      "bertscore_r": 0.6025142669677734,
      "bertscore_f1": 0.590478241443634,
      "bertsim": 0.41991767287254333,
      "cider": 3.032205753544744e-41
    }
  },
  {
    "id": "47",
    "task": "multisubimageVQA",
    "model": "healthgpt",
    "question": "How do the histological features observed in the experimental group (Fig-1 and Fig-2) differ from those in the control group (Fig-3)?",
    "reference_answer": "In the experimental group (Fig-1 and Fig-2), the histological sections show extensive inflammatory cell infiltration, significant vascular injury with disrupted endothelial lining and thrombus formation, and areas of myocardial necrosis, corresponding to an ISHLT grade 4 rejection. In contrast, the control group (Fig-3) exhibits mild infiltration without evident necrosis, corresponding to an ISHLT grade 1B-2, indicating moderate inflammation but no severe damage or cell death.",
    "prediction": "The histological features in the experimental group (Fig-1 and Fig-2) show significant pathological changes compared to the control group (Fig-3). In the experimental group, there is a marked increase in inflammatory cell infiltration, indicating an active inflammatory response. Additionally, there is noticeable edema, which is characterized by the presence of excess fluid in the interstitial spaces. These changes suggest tissue damage and an ongoing inflammatory process. In contrast, the control group (Fig-3) exhibits normal histological architecture with well-preserved tissue structure and no signs of inflammation or edema. This stark difference highlights the impact of the experimental conditions on the tissue, leading to significant pathological alterations.",
    "metrics": {
      "bleu1": 0.3153153153153153,
      "bleu2": 0.20735848908965118,
      "bleu3": 0.16310600187083926,
      "bleu4": 0.13389643515249477,
      "rouge-1": 0.40983606068261225,
      "rouge-2": 0.18181817709141518,
      "rouge-l": 0.37704917543671057,
      "em": 0,
      "f1": 0.4065040650406504,
      "precision": 0.352112676056338,
      "recall": 0.4807692307692308,
      "bertscore_p": 0.6487284898757935,
      "bertscore_r": 0.6604753732681274,
      "bertscore_f1": 0.654549241065979,
      "bertsim": 0.6100175976753235,
      "cider": 2.752533652746389e-10
    }
  },
  {
    "id": "48",
    "task": "multisubimageVQA",
    "model": "healthgpt",
    "question": "How do the staining patterns of decorin and collagen IX in the superficial and deeper zones of tarsometatarsal joint cartilage differ according to the selected sub-images (Fig-2 and Fig-3)?",
    "reference_answer": "In the superficial zone of tarsometatarsal joint cartilage, both decorin and collagen IX are highly enriched and show some overlap. However, in the deeper two-thirds of the tissue, collagen IX is predominantly localized in the territorial matrix surrounding chondrocytes, while decorin is more concentrated in the interterritorial matrix. This differential localization highlights the unique roles of these molecules in different zones of the cartilage structure.",
    "prediction": "The staining patterns of decorin and collagen IX in the superficial and deeper zones of tarsometatarsal joint cartilage show distinct differences. In the superficial zone (Fig-2), both decorin and collagen IX exhibit a dense and uniform staining pattern, indicating a high concentration of these proteins. This uniformity suggests a well-organized extracellular matrix in the superficial zone. In contrast, the deeper zone (Fig-3) shows a more heterogeneous staining pattern for both decorin and collagen IX. The distribution of these proteins is less uniform, with some areas showing higher concentrations and others showing lower concentrations. This heterogeneity in the deeper zone may reflect variations in the extracellular matrix composition and organization, which could be due to different functional requirements or stages of cartilage development and maintenance. The differences in staining patterns between the superficial and deeper zones highlight the distinct structural and functional characteristics of these regions within the tarsometatarsal joint cartilage.",
    "metrics": {
      "bleu1": 0.2802547770700637,
      "bleu2": 0.17475864694118018,
      "bleu3": 0.11131351485217135,
      "bleu4": 0.07199644551310873,
      "rouge-1": 0.36507936044343664,
      "rouge-2": 0.13333332892654337,
      "rouge-l": 0.3492063445704208,
      "em": 0,
      "f1": 0.3458646616541353,
      "precision": 0.26744186046511625,
      "recall": 0.48936170212765956,
      "bertscore_p": 0.6038802862167358,
      "bertscore_r": 0.6535288095474243,
      "bertscore_f1": 0.6277243494987488,
      "bertsim": 0.8660511374473572,
      "cider": 3.4267084695511394e-44
    }
  },
  {
    "id": "49",
    "task": "multisubimageVQA",
    "model": "healthgpt",
    "question": "How do the axial CT and fused axial FDG PET-CT images (Fig-1 and Fig-2) help in distinguishing the peripheral squamous cell carcinoma from the underlying fibrotic lung tissue?",
    "reference_answer": "The axial CT image (Fig-1) shows the tumor's irregular margins and heterogeneous density, along with reticular opacities and honeycombing consistent with UIP. The fused axial FDG PET-CT image (Fig-2) reveals increased metabolic activity in the tumor, with an SUVmax of 12.5, which is significantly higher than the lower metabolic activity in the fibrotic lung parenchyma. This differential uptake helps in clearly distinguishing the high metabolic activity of the tumor from the lower metabolic activity of the fibrotic areas, thus aiding in the accurate diagnosis and differentiation of the squamous cell carcinoma from the underlying UIP pattern.",
    "prediction": "The axial CT image (Fig-1) and the fused axial FDG PET-CT image (Fig-2) provide complementary information that aids in distinguishing the peripheral squamous cell carcinoma from the underlying fibrotic lung tissue. The axial CT image (Fig-1) shows the anatomical details of the lung parenchyma, including the presence of fibrotic changes. However, it may be challenging to differentiate the tumor from the fibrotic tissue based solely on the CT findings. The fused axial FDG PET-CT image (Fig-2) combines the anatomical information from the CT scan with the functional information from the FDG PET scan. The FDG PET component highlights areas of increased metabolic activity, which is a characteristic feature of malignant tumors like squamous cell carcinoma. By overlaying the FDG PET data onto the CT image, the fused image (Fig-2) clearly delineates the peripheral squamous cell carcinoma as a region of increased FDG uptake, distinct from the surrounding fibrotic lung tissue. This fusion of anatomical and functional information enhances the diagnostic accuracy and aids in the precise localization and characterization of the tumor, which is crucial for treatment planning and monitoring.",
    "metrics": {
      "bleu1": 0.29411764705882354,
      "bleu2": 0.22140372138502384,
      "bleu3": 0.1651514312821858,
      "bleu4": 0.13356514461681848,
      "rouge-1": 0.3896103847756789,
      "rouge-2": 0.23999999534380254,
      "rouge-l": 0.324675319840614,
      "em": 0,
      "f1": 0.38216560509554137,
      "precision": 0.3191489361702128,
      "recall": 0.47619047619047616,
      "bertscore_p": 0.6469236016273499,
      "bertscore_r": 0.6771794557571411,
      "bertscore_f1": 0.6617058515548706,
      "bertsim": 0.8270134925842285,
      "cider": 3.786311674309334e-43
    }
  }
]